_pmid,_doi,_publicationTitle,_year,_context,_confidence,_verdict,_usageType,strainNomenclature,backgroundStrain,backgroundSubstrain,animalModelGeneticDisorder,animalModelOfManifestation,transplantationType,animalState,generation,donorId,transplantationDonorId
PMID:31545171,10.7554/eLife.48983,Optical dopamine monitoring with dLight1 reveals mesolimbic phenotypes in a mouse model of neurofibromatosis type 1.,,Experimental subjects were 8–12 week old 129T2/SvEmsJ::C57Bl/6NTac Nf1+/+ and Nf1+/- male and female mice that were generated via the F1 cross,0.95,Accept,Experimental Usage,129T2/SvEmsJ::C57Bl/6NTac Nf1+/- and Nf1+/+,129T2/SvEmsJ x C57Bl/6NTac,,Neurofibromatosis type 1,,,,,,
PMID:32642734,10.1093/noajnl/vdz026,Whole exome sequencing reveals the maintained polyclonal nature from primary to metastatic malignant peripheral nerve sheath tumor in two patients with NF1.,,Murine MPNST tumor lines established from C57BL6/J Nf1+/−;Trp53+/− (NPcis) expressing GFP-Luciferase,0.95,Accept,Experimental Usage,C57BL6/J Nf1+/−;Trp53+/−,C57BL/6,C57BL/6J,Neurofibromatosis type 1,Malignant Peripheral Nerve Sheath Tumor,,,,,
PMID:32642734,10.1093/noajnl/vdz026,Whole exome sequencing reveals the maintained polyclonal nature from primary to metastatic malignant peripheral nerve sheath tumor in two patients with NF1.,,injecting 1 × 10 5 cells into the medial flank 4-week-old male B6N-Tyrc-Brd/BrdCrCrl mice (Charles Rivers),0.9,Accept,Experimental Usage,B6N-Tyrc-Brd/BrdCrCrl,,,No known disease,,,,,,
PMID:35589737,10.1038/s41467-022-30466-6,Neuronal hyperexcitability drives central and peripheral nervous system tumor progression in models of neurofibromatosis-1.,,Heterozygous Nf1 c.5425 C > T ; Arg1809Cys-mutant mice were generated by CRISPR/Cas9 engineering directly into C57Bl/6J embryos,0.95,Accept,Experimental Usage,Nf1 c.5425 C > T ; Arg1809Cys,C57BL/6,C57BL/6J,Neurofibromatosis type 1,Non-tumor forming mutation,,,,,
PMID:35589737,10.1038/s41467-022-30466-6,Neuronal hyperexcitability drives central and peripheral nervous system tumor progression in models of neurofibromatosis-1.,,heterozygous R681X and c.3827G > C Nf1-mutant mice were backcrossed to C57Bl/6J,0.9,Accept,Experimental Usage,R681X Nf1,C57BL/6,C57BL/6J,Neurofibromatosis type 1,,,,,,
PMID:35589737,10.1038/s41467-022-30466-6,Neuronal hyperexcitability drives central and peripheral nervous system tumor progression in models of neurofibromatosis-1.,,conditional knockout Nf1 flox/flox ; Hoxb7-Cre mice were used,0.95,Accept,Experimental Usage,Nf1 flox/flox ; Hoxb7-Cre,,,Neurofibromatosis type 1,Plexiform Neurofibroma,,,,,
PMID:35589737,10.1038/s41467-022-30466-6,Neuronal hyperexcitability drives central and peripheral nervous system tumor progression in models of neurofibromatosis-1.,,Optic glioma-prone mice were generated with the R1809C mutation or a neomycin cassette inserted in exon 31 as the germline Nf1 allele and somatic Nf1 inactivation in neuroglial progenitor cells (Nf1 f/neo ; hGFAP-Cre mice),0.95,Accept,Experimental Usage,Nf1 f/neo ; hGFAP-Cre,,,Neurofibromatosis type 1,Optic Nerve Glioma,,,,,
PMID:35589737,10.1038/s41467-022-30466-6,Neuronal hyperexcitability drives central and peripheral nervous system tumor progression in models of neurofibromatosis-1.,,"8-week-old athymic nude mice (Charles River, Stock No. 490) underwent surgery to implant pNF progenitor cells",0.9,Accept,Experimental Usage,"athymic nude mice (Charles River, Stock No. 490)",,,No known disease,,,,,,
PMID:28465357,10.1101/gad.298703.117,Identification of hair shaft progenitors that create a niche for hair pigmentation.,,"K14Cre (Dassule et al. 2000), K14CreERT (Vasioukhin et al. 1999), TyrCreERT2 (Bosenberg et al. 2006)... mice were purchased from the Jackson Laboratory",0.85,Accept,Experimental Usage,K14Cre,,,No known disease,,,,,,
PMID:28465357,10.1101/gad.298703.117,Identification of hair shaft progenitors that create a niche for hair pigmentation.,,"K14Cre (Dassule et al. 2000), K14CreERT (Vasioukhin et al. 1999), TyrCreERT2 (Bosenberg et al. 2006)... mice were purchased from the Jackson Laboratory",0.85,Accept,Experimental Usage,K14CreERT,,,No known disease,,,,,,
PMID:28465357,10.1101/gad.298703.117,Identification of hair shaft progenitors that create a niche for hair pigmentation.,,"K14Cre (Dassule et al. 2000), K14CreERT (Vasioukhin et al. 1999), TyrCreERT2 (Bosenberg et al. 2006)... mice were purchased from the Jackson Laboratory",0.85,Accept,Experimental Usage,TyrCreERT2,,,No known disease,,,,,,
PMID:28465357,10.1101/gad.298703.117,Identification of hair shaft progenitors that create a niche for hair pigmentation.,,"R26-rtTA (Belteki et al. 2005), and tetO-DTA (Lee et al. 1998) mice were purchased from the Jackson Laboratory",0.85,Accept,Experimental Usage,R26-rtTA,,,No known disease,,,,,,
PMID:28465357,10.1101/gad.298703.117,Identification of hair shaft progenitors that create a niche for hair pigmentation.,,"R26-rtTA (Belteki et al. 2005), and tetO-DTA (Lee et al. 1998) mice were purchased from the Jackson Laboratory",0.85,Accept,Experimental Usage,tetO-DTA,,,No known disease,,,,,,
PMID:28465357,10.1101/gad.298703.117,Identification of hair shaft progenitors that create a niche for hair pigmentation.,,K14-Scf (Kunisada et al. 1998a) was kindly provided by Dr. John Harris (University of Massachusetts Medical School),0.85,Accept,Experimental Usage,K14-Scf,,,No known disease,,,,,,
PMID:28465357,10.1101/gad.298703.117,Identification of hair shaft progenitors that create a niche for hair pigmentation.,,"Krox20Cre (Voiculescu et al. 2000), DhhCre (Skucas et al. 2013), PLPCreERT2 (Leone et al. 2003)... were described previously",0.85,Accept,Experimental Usage,Krox20Cre,,,No known disease,,,,,,
PMID:28465357,10.1101/gad.298703.117,Identification of hair shaft progenitors that create a niche for hair pigmentation.,,"Krox20Cre (Voiculescu et al. 2000), DhhCre (Skucas et al. 2013), PLPCreERT2 (Leone et al. 2003)... were described previously",0.85,Accept,Experimental Usage,DhhCre,,,No known disease,,,,,,
PMID:28465357,10.1101/gad.298703.117,Identification of hair shaft progenitors that create a niche for hair pigmentation.,,"Krox20Cre (Voiculescu et al. 2000), DhhCre (Skucas et al. 2013), PLPCreERT2 (Leone et al. 2003)... were described previously",0.85,Accept,Experimental Usage,PLPCreERT2,,,No known disease,,,,,,
PMID:28465357,10.1101/gad.298703.117,Identification of hair shaft progenitors that create a niche for hair pigmentation.,,"CMVCreERT (Hayashi and McMahon 2002), R26-LacZ, and R26-YFP were described previously",0.85,Accept,Experimental Usage,CMVCreERT,,,No known disease,,,,,,
PMID:28465357,10.1101/gad.298703.117,Identification of hair shaft progenitors that create a niche for hair pigmentation.,,"CMVCreERT (Hayashi and McMahon 2002), R26-LacZ, and R26-YFP were described previously",0.85,Accept,Experimental Usage,R26-LacZ,,,No known disease,,,,,,
PMID:28465357,10.1101/gad.298703.117,Identification of hair shaft progenitors that create a niche for hair pigmentation.,,"CMVCreERT (Hayashi and McMahon 2002), R26-LacZ, and R26-YFP were described previously",0.85,Accept,Experimental Usage,R26-YFP,,,No known disease,,,,,,
PMID:38216123,10.1016/j.molmet.2024.101876,NF1 deficiency drives metabolic reprogramming in ER+ breast cancer.,,The Nf1 inframe indel (Nf1-IF) rats have a 54bp deletion in exon 20,0.95,Accept,Experimental Usage,Nf1-IF,,,Neurofibromatosis type 1,mammary adenocarcinomas,,,,,
PMID:38216123,10.1016/j.molmet.2024.101876,NF1 deficiency drives metabolic reprogramming in ER+ breast cancer.,,The Nf1 premature stop indel (Nf1-PS) rats have an 8-bp deletion in exon 20,0.95,Accept,Experimental Usage,Nf1-PS,,,Neurofibromatosis type 1,mammary adenocarcinomas,,,,,
PMID:38216123,10.1016/j.molmet.2024.101876,NF1 deficiency drives metabolic reprogramming in ER+ breast cancer.,,The Nf1 in-frame premature stop indel (Nf1-IFPS) rats have a 57-bp deletion in exon 20,0.95,Accept,Experimental Usage,Nf1-IFPS,,,Neurofibromatosis type 1,mammary adenocarcinomas,,,,,
PMID:34930951,10.1038/s41536-021-00195-3,A bioinspired gelatin-hyaluronic acid-based hybrid interpenetrating network for the enhancement of retinal ganglion cells replacement therapy.,,"Twenty-seven female Long Evans rats (age 12 weeks, approximate weight 200 g, Charles River. Wilmington, MA) were used in the experiments.",0.85,Accept,Experimental Usage,Long Evans,Long Evans,,No known disease,,,,,,
PMID:20200958,10.1002/jbmr.42,Local low-dose lovastatin delivery improves the bone-healing defect caused by Nf1 loss of function in osteoblasts.,,we assessed bone healing in the Nf1(ob) (-/-) conditional mouse model lacking Nf1 specifically in osteoblasts,0.9,Accept,Experimental Usage,Nf1(ob) (-/-),,,Neurofibromatosis type 1,Bone healing defects,,,,,
PMID:20200958,10.1002/jbmr.42,Local low-dose lovastatin delivery improves the bone-healing defect caused by Nf1 loss of function in osteoblasts.,,WT and mice were generated by crossing 2.3-kb α1(I) collagen-cre Nf1 flox/flox mice and Nf1 flox/flox mice,0.85,Accept,Experimental Usage,2.3-kb α1(I) collagen-cre Nf1 flox/flox,,,Neurofibromatosis type 1,,,,,,
PMID:20200958,10.1002/jbmr.42,Local low-dose lovastatin delivery improves the bone-healing defect caused by Nf1 loss of function in osteoblasts.,,crossing 2.3-kb α1(I) collagen-cre Nf1 flox/flox mice and Nf1 flox/flox mice,0.85,Accept,Experimental Usage,Nf1 flox/flox,,,Neurofibromatosis type 1,,,,,,
PMID:33078583,10.1002/jcsm.12632,Cell autonomous requirement of neurofibromin (Nf1) for postnatal muscle hypertrophic growth and metabolic homeostasis.,,Mouse lines used in this study were described before: Myf5 Cre,0.9,Accept,Experimental Usage,Myf5 Cre,,,No known disease,,,,,,
PMID:33078583,10.1002/jcsm.12632,Cell autonomous requirement of neurofibromin (Nf1) for postnatal muscle hypertrophic growth and metabolic homeostasis.,,"Mouse lines used in this study were described before: Myf5 Cre, Lbx1 Cre",0.9,Accept,Experimental Usage,Lbx1 Cre,,,No known disease,,,,,,
PMID:33078583,10.1002/jcsm.12632,Cell autonomous requirement of neurofibromin (Nf1) for postnatal muscle hypertrophic growth and metabolic homeostasis.,,"Mouse lines used in this study were described before: Myf5 Cre, Lbx1 Cre, Nf1 flox",0.95,Accept,Experimental Usage,Nf1 flox,,,Neurofibromatosis type 1,,,,,,
PMID:33078583,10.1002/jcsm.12632,Cell autonomous requirement of neurofibromin (Nf1) for postnatal muscle hypertrophic growth and metabolic homeostasis.,,"Mouse lines used in this study were described before: Myf5 Cre, Lbx1 Cre, Nf1 flox, and Rosa26 mTmG",0.9,Accept,Experimental Usage,Rosa26 mTmG,,,No known disease,,,,,,
PMID:38201517,10.3390/cancers16010089,Synergistic Suppression of NF1 Malignant Peripheral Nerve Sheath Tumor Cell Growth in Culture and Orthotopic Xenografts by Combinational Treatment with Statin and Prodrug Farnesyltransferase Inhibitor PAMAM G4 Dendrimers.,,Female NOD SCID (NOD.CB17-Prkdc/NCrCrl) mice from Charles River Laboratories were housed in barrier facilities designed for immune-compromised animals.,0.95,Accept,Experimental Usage,NOD.CB17-Prkdc/NCrCrl,NOD,,No known disease,,,,,,
PMID:38201517,10.3390/cancers16010089,Synergistic Suppression of NF1 Malignant Peripheral Nerve Sheath Tumor Cell Growth in Culture and Orthotopic Xenografts by Combinational Treatment with Statin and Prodrug Farnesyltransferase Inhibitor PAMAM G4 Dendrimers.,,Initial range-finding studies employed female Balb/c mice (Taconic Laboratories).,0.9,Accept,Experimental Usage,Balb/c,BALB/c,,No known disease,,,,,,
PMID:32781282,10.1016/j.trsl.2020.08.001,Nf1 heterozygous mice recapitulate the anthropometric and metabolic features of human neurofibromatosis type 1.,,Nf1 heterozygous (Nf1+/-) mice accurately reflect the dominant inheritance of NF1 and are regularly employed as a model of NF1,0.95,Accept,Experimental Usage,Nf1+/-,C57BL/6,C57BL/6J,Neurofibromatosis type 1,,,,,,
PMID:30617350,10.1038/s41596-018-0105-7,"A cerebellopontine angle mouse model for the investigation of tumor biology, hearing, and neurological function in NF2-related vestibular schwannoma.",,"Syngeneic immune-competent FVB/C57BL/6 mice, both male and female, 10–12 weeks old, are used for implantation of the mouse NF2 −/− Schwann cell line.",0.85,Accept,Experimental Usage,FVB/C57BL/6,FVB/C57BL/6,,No known disease,,,,,,
PMID:30617350,10.1038/s41596-018-0105-7,"A cerebellopontine angle mouse model for the investigation of tumor biology, hearing, and neurological function in NF2-related vestibular schwannoma.",,"When using human VS cell lines, such as the established human HEI-193 cell line or other immortalized human VS cell lines, immune-deficient mice (e.g., nude mice (nu/nu) or NOD SCID mice) should be used.",0.85,Accept,Experimental Usage,nude mice (nu/nu),,,No known disease,,,,,,
PMID:30617350,10.1038/s41596-018-0105-7,"A cerebellopontine angle mouse model for the investigation of tumor biology, hearing, and neurological function in NF2-related vestibular schwannoma.",,"When using human VS cell lines, such as the established human HEI-193 cell line or other immortalized human VS cell lines, immune-deficient mice (e.g., nude mice (nu/nu) or NOD SCID mice) should be used.",0.85,Accept,Experimental Usage,NOD SCID,,,No known disease,,,,,,
PMID:27956228,10.1053/j.gastro.2016.12.002,Genome-Wide CRISPR Screen Identifies Regulators of Mitogen-Activated Protein Kinase as Suppressors of Liver Tumors in Mice.,,"3 × 10^6 p53−/−; Myc; Cas9 cells were injected into flanks of 6-8-week old, female, NCI Nu/Nu mice (Taconic)",0.9,Accept,Experimental Usage,Nu/Nu,,,No known disease,,,,,,
PMID:27956228,10.1053/j.gastro.2016.12.002,Genome-Wide CRISPR Screen Identifies Regulators of Mitogen-Activated Protein Kinase as Suppressors of Liver Tumors in Mice.,,p53 mice were crossed with Albumin-Cre mice (Jackson Laboratories) flox/flox,0.85,Accept,Experimental Usage,p53 flox/flox,,,No known disease,,,,,,
PMID:27956228,10.1053/j.gastro.2016.12.002,Genome-Wide CRISPR Screen Identifies Regulators of Mitogen-Activated Protein Kinase as Suppressors of Liver Tumors in Mice.,,p53 mice were crossed with Albumin-Cre mice (Jackson Laboratories) flox/flox,0.85,Accept,Experimental Usage,Albumin-Cre,,,No known disease,,,,,,
PMID:27956228,10.1053/j.gastro.2016.12.002,Genome-Wide CRISPR Screen Identifies Regulators of Mitogen-Activated Protein Kinase as Suppressors of Liver Tumors in Mice.,,Kras G12D;shp53 mouse cholangiocarcinoma was generated as in using Kras LSL-G12D/+ liver progenitor cells,0.85,Accept,Experimental Usage,Kras LSL-G12D/+,,,No known disease,,,,,,
PMID:24595234,10.1371/journal.pone.0090853,In vivo functional analysis of the human NF2 tumor suppressor gene in Drosophila.,,"crossed to female flies of the following genotype, y w Mer4",0.9,Accept,Experimental Usage,y w Mer4,,,Neurofibromatosis type 2,,,,,,
PMID:24595234,10.1371/journal.pone.0090853,In vivo functional analysis of the human NF2 tumor suppressor gene in Drosophila.,,surviving 4/FM7; T80-Gal4 y w Mer4 hemizygous males,0.85,Accept,Experimental Usage,4/FM7; T80-Gal4 y w Mer4,,,Neurofibromatosis type 2,,,,,,
PMID:30479396,10.1038/s41467-018-07452-y,NF1 heterozygosity fosters de novo tumorigenesis but impairs malignant transformation.,,"K14 Cre mice were available from the Jackson Laboratory (Bar Harbor, ME). All mice were maintained on a mix C57bl/6 background.",0.9,Accept,Experimental Usage,K14 Cre,C57BL/6,,No known disease,,,,,,
PMID:30479396,10.1038/s41467-018-07452-y,NF1 heterozygosity fosters de novo tumorigenesis but impairs malignant transformation.,,PLP CreERT2; Nf1 f/−; ROSA-LacZ mice was conditionally activated with a single subcutaneous dose of 4-hydroxytamoxifen,0.95,Accept,Experimental Usage,PLP CreERT2; Nf1 f/−; ROSA-LacZ,,,Neurofibromatosis type 1,Malignant Peripheral Nerve Sheath Tumor,,,,,
PMID:21726432,10.1186/1741-7015-9-82,MIA is a potential biomarker for tumour load in neurofibromatosis type 1.,,mice bearing conditional inactivation of NF1 in the developing limbs...Nf1Prx1 mouse model might prove to be relevant biomarkers,0.9,Accept,Experimental Usage,Nf1Prx1,C57BL/6J,,Neurofibromatosis type 1,bone dysplasia,,,,,
PMID:21726432,10.1186/1741-7015-9-82,MIA is a potential biomarker for tumour load in neurofibromatosis type 1.,,The female Nf1flox mice were crossed to male Nf1flox heterozygous Prx1-Cre-positive males,0.85,Accept,Experimental Usage,Nf1flox,C57BL/6J,,Neurofibromatosis type 1,,,,,,
PMID:19191334,10.1002/glia.20845,Microarray analyses reveal regional astrocyte heterogeneity with implications for neurofibromatosis type 1 (NF1)-regulated glial proliferation.,,Nf1flox/flox (Zhu et al. 2001) and Nf1GFAP CKO (Bajenaru et al. 2002) mice were generated as previously described and maintained on a C57Bl/6 background,0.9,Accept,Experimental Usage,Nf1flox/flox,C57BL/6,,Neurofibromatosis type 1,,,,,,
PMID:19191334,10.1002/glia.20845,Microarray analyses reveal regional astrocyte heterogeneity with implications for neurofibromatosis type 1 (NF1)-regulated glial proliferation.,,Nf1flox/flox (Zhu et al. 2001) and Nf1GFAP CKO (Bajenaru et al. 2002) mice were generated as previously described and maintained on a C57Bl/6 background,0.9,Accept,Experimental Usage,Nf1GFAP CKO,C57BL/6,,Neurofibromatosis type 1,,,,,,
PMID:29402968,10.1038/s41598-018-20894-0,Integrating Functional Analysis in the Next-Generation Sequencing Diagnostic Pipeline of RASopathies.,,RNA transcripts were injected into zebrafish embryos at the single-cell stage. GFP signals in the zebrafish embryos indicated synthetic RNA expression,0.9,Accept,Experimental Usage,zebrafish,,,No known disease,,,,,,
PMID:23225063,10.1002/ana.23793,Dopamine deficiency underlies learning deficits in neurofibromatosis-1 mice.,,Nf1 +/− GFAP CKO (CKO) with one non-functional Nf1 allele in all somatic cells and complete Nf1 loss in GFAP+ (glial) cells,0.9,Accept,Experimental Usage,Nf1 +/− GFAP CKO,C57BL/6,,Neurofibromatosis type 1,,,,,,
PMID:23225063,10.1002/ana.23793,Dopamine deficiency underlies learning deficits in neurofibromatosis-1 mice.,,littermate control Nf1 flox/flox (CTL) mice were maintained on an inbred C57BL/6 background,0.9,Accept,Experimental Usage,Nf1 flox/flox,C57BL/6,,No known disease,,,,,,
PMID:21199799,10.1158/0008-5472.CAN-10-2732,Dose-dependent effects of focal fractionated irradiation on secondary malignant neoplasms in Nf1 mutant mice.,,"Nf1 +/− mice were generated as previously described (11). In brief, Nf1 +/− mice maintained in the 129/Sv background (12) were crossed with wild-type C57Bl/6 mice.",0.95,Accept,Experimental Usage,Nf1+/-,129/Sv x C57BL/6,,Neurofibromatosis type 1,,,,,,
PMID:21439418,10.1016/j.bone.2011.03.760,Primary osteopathy of vertebrae in a neurofibromatosis type 1 murine model.,,"we report a novel murine NF1 model, Nf1(flox/-);Col2.3Cre(+) mice. These mice display short vertebral segments",0.95,Accept,Development,Nf1(flox/-);Col2.3Cre(+),,,Neurofibromatosis type 1,Spinal deformities,,,,,
PMID:21439418,10.1016/j.bone.2011.03.760,Primary osteopathy of vertebrae in a neurofibromatosis type 1 murine model.,,Nf1 +/− mice were obtained from Dr. Tyler Jacks at the Massachusetts Institute of Technology,0.9,Accept,Experimental Usage,Nf1 +/−,,,Neurofibromatosis type 1,,,,,,
PMID:21439418,10.1016/j.bone.2011.03.760,Primary osteopathy of vertebrae in a neurofibromatosis type 1 murine model.,,Nf1 flox/flox mice were provided by Dr. Luis Parada at the University of Texas Southwestern Medical Center,0.9,Accept,Experimental Usage,Nf1 flox/flox,,,Neurofibromatosis type 1,,,,,,
PMID:21439418,10.1016/j.bone.2011.03.760,Primary osteopathy of vertebrae in a neurofibromatosis type 1 murine model.,,"Col2.3Cre transgenic mice were generated as described elsewhere. In this model, the 2.3 α1(I) Collagen promoter is used to selectively drive Cre expression",0.85,Accept,Experimental Usage,Col2.3Cre,,,No known disease,,,,,,
PMID:21439418,10.1016/j.bone.2011.03.760,Primary osteopathy of vertebrae in a neurofibromatosis type 1 murine model.,,Col2.3Cre transgenic mice were crossed with ROSA26 reporter mice. LacZ staining was performed to assess Cre recombination,0.85,Accept,Experimental Usage,ROSA26,,,No known disease,,,,,,
PMID:32699356,10.1038/s41467-020-17382-3,Murine models of IDH-wild-type glioblastoma exhibit spatial segregation of tumor initiation and manifestation during evolution.,,The floxed p53 alleles (p53floxE2–10) and (p53LSLR172H) have been described previously,0.85,Accept,Experimental Usage,p53floxE2–10,,,No known disease,,,,,,
PMID:32699356,10.1038/s41467-020-17382-3,Murine models of IDH-wild-type glioblastoma exhibit spatial segregation of tumor initiation and manifestation during evolution.,,The floxed p53 alleles (p53floxE2–10) and (p53LSLR172H) have been described previously,0.85,Accept,Experimental Usage,p53LSLR172H,,,No known disease,,,,,,
PMID:32699356,10.1038/s41467-020-17382-3,Murine models of IDH-wild-type glioblastoma exhibit spatial segregation of tumor initiation and manifestation during evolution.,,"p53 null CKO (p53ΔE2–10 CKO, hGFAP-cre+; p53floxE2–10/floxE2–10) and p53R172H CKO",0.9,Accept,Experimental Usage,hGFAP-cre+; p53floxE2–10/floxE2–10,C57Bl6 and 129S1/Svj,,No known disease,,,,,,
PMID:32699356,10.1038/s41467-020-17382-3,Murine models of IDH-wild-type glioblastoma exhibit spatial segregation of tumor initiation and manifestation during evolution.,,p53R172H CKO (hGFAP-cre+; p53LSLR172H/floxE2–10) mice analyzed in this study,0.9,Accept,Experimental Usage,hGFAP-cre+; p53LSLR172H/floxE2–10,C57Bl6 and 129S1/Svj,,No known disease,,,,,,
PMID:32461556,10.1038/s41467-020-16432-0,Assessing the origin of high-grade serous ovarian cancer using CRISPR-modification of mouse organoids.,,"Wild-type C57BL/6 and B6J.129(B6N)-Gt(ROSA)26Sor (JAX stock #026175) tm1(CAG-cas9*,-EGFP)Fezh/J mice strains were used",0.9,Accept,Experimental Usage,C57BL/6,C57BL/6,,No known disease,,,,,,
PMID:32461556,10.1038/s41467-020-16432-0,Assessing the origin of high-grade serous ovarian cancer using CRISPR-modification of mouse organoids.,,"B6J.129(B6N)-Gt(ROSA)26Sor (JAX stock #026175) tm1(CAG-cas9*,-EGFP)Fezh/J mice strains were used for derivation of wild-type and Cas9/GFP-expressing organoids",0.95,Accept,Experimental Usage,"B6J.129(B6N)-Gt(ROSA)26Sor tm1(CAG-cas9*,-EGFP)Fezh/J",C57BL/6,,No known disease,,,,,,
PMID:32461556,10.1038/s41467-020-16432-0,Assessing the origin of high-grade serous ovarian cancer using CRISPR-modification of mouse organoids.,,NOD scid gamma (NSG; NOD.Cg-Prkdc scid Il2rg tm1Wjl /SzJ mice were used. Transplantation experiments were performed,0.95,Accept,Experimental Usage,NOD.Cg-Prkdc scid Il2rg tm1Wjl /SzJ,,,No known disease,,,,,,
PMID:34415582,10.1002/glia.24075,Notch signaling via Hey1 and Id2b regulates Müller glia's regenerative response to retinal injury.,,"1016 tuba1a:GFP, gfap:GFP, hsp70:DN-MAML-GFP, gfap:mCherry and tp1:mCherry, fish were previously described",0.9,Accept,Experimental Usage,1016 tuba1a:GFP,,,No known disease,,,,,,
PMID:34415582,10.1002/glia.24075,Notch signaling via Hey1 and Id2b regulates Müller glia's regenerative response to retinal injury.,,"1016 tuba1a:GFP, gfap:GFP, hsp70:DN-MAML-GFP, gfap:mCherry and tp1:mCherry, fish were previously described",0.9,Accept,Experimental Usage,gfap:GFP,,,No known disease,,,,,,
PMID:34415582,10.1002/glia.24075,Notch signaling via Hey1 and Id2b regulates Müller glia's regenerative response to retinal injury.,,"1016 tuba1a:GFP, gfap:GFP, hsp70:DN-MAML-GFP, gfap:mCherry and tp1:mCherry, fish were previously described",0.9,Accept,Experimental Usage,hsp70:DN-MAML-GFP,,,No known disease,,,,,,
PMID:34415582,10.1002/glia.24075,Notch signaling via Hey1 and Id2b regulates Müller glia's regenerative response to retinal injury.,,"1016 tuba1a:GFP, gfap:GFP, hsp70:DN-MAML-GFP, gfap:mCherry and tp1:mCherry, fish were previously described",0.9,Accept,Experimental Usage,gfap:mCherry,,,No known disease,,,,,,
PMID:34415582,10.1002/glia.24075,Notch signaling via Hey1 and Id2b regulates Müller glia's regenerative response to retinal injury.,,"1016 tuba1a:GFP, gfap:GFP, hsp70:DN-MAML-GFP, gfap:mCherry and tp1:mCherry, fish were previously described",0.9,Accept,Experimental Usage,tp1:mCherry,,,No known disease,,,,,,
PMID:38502231,10.1172/JCI176748,STING activation reprograms the microenvironment to sensitize NF1-related malignant peripheral nerve sheath tumors for immunotherapy.,,"The cisNP mouse model has been previously described (27, 28).",0.9,Accept,Experimental Usage,cisNP,,,Neurofibromatosis type 1,Malignant Peripheral Nerve Sheath Tumor,,,,,
PMID:38502231,10.1172/JCI176748,STING activation reprograms the microenvironment to sensitize NF1-related malignant peripheral nerve sheath tumors for immunotherapy.,,Athymic nude mice were purchased from Charles River Laboratories (stock no. 553).,0.85,Accept,Experimental Usage,athymic nude mice,,,No known disease,,,,,,
PMID:30542164,10.1038/s41586-018-0774-y,Disruption of a self-amplifying catecholamine loop reduces cytokine release syndrome.,,"For subcutaneous CT26 tumour implantation, LPS and CLP experiments, female C57Bl/6 and BALB/C mice of 6–8 weeks were purchased from Harlan Laboratories.",0.85,Accept,Experimental Usage,C57Bl/6,C57BL/6,,No known disease,,,,,,
PMID:30542164,10.1038/s41586-018-0774-y,Disruption of a self-amplifying catecholamine loop reduces cytokine release syndrome.,,"For subcutaneous CT26 tumour implantation, LPS and CLP experiments, female C57Bl/6 and BALB/C mice of 6–8 weeks were purchased from Harlan Laboratories.",0.85,Accept,Experimental Usage,BALB/C,BALB/c,,No known disease,,,,,,
PMID:30542164,10.1038/s41586-018-0774-y,Disruption of a self-amplifying catecholamine loop reduces cytokine release syndrome.,,"For the CART19 treatment, NSG-SGM3 (NSGS) mice (stock number 013062) were purchased from the Jackson Laboratory.",0.9,Accept,Experimental Usage,"NOD.Cg-Prkdcscid Il2rgtm1Wjl Tg(CMV-IL3,CSF2,KITLG)1Eav/MloySzJ",NOD,,No known disease,,,,,,
PMID:30542164,10.1038/s41586-018-0774-y,Disruption of a self-amplifying catecholamine loop reduces cytokine release syndrome.,,"LysMcre mice were purchased from Jackson Laboratory (stock number 004781), in which a nuclear-localized Cre recombinase was inserted into the first coding exon of the lysozyme 2 (Lyz2 or LysM) gene",0.9,Accept,Experimental Usage,LysMcre Thfl/fl,C57BL/6,,No known disease,,,,,,
PMID:41022755,10.1038/s41467-025-63619-4,Development of an adeno-associated virus vector for gene replacement therapy of NF1-related tumors.,,"150,000 cells in 3 µl were implanted in the sciatic nerve of NSG mice (female, 6–10 weeks old)",0.9,Accept,Experimental Usage,NSG,,,No known disease,,,,,,
PMID:39269317,10.1158/1078-0432.CCR-24-1750,MEK Inhibitors Lead to PDGFR Pathway Upregulation and Sensitize Tumors to RAF Dimer Inhibitors in NF1-Deficient Malignant Peripheral Nerve Sheath Tumor.,,"subcutaneously injected into both flanks of 6- to 8-week-old female CB17 SCID mice (Taconic, RRID: MSR_TAC:cb17sc)",0.9,Accept,Experimental Usage,CB17 SCID,CB17,,No known disease,,,,,,
PMID:39129390,10.1002/1878-0261.13704,Inhibition of autophagy as a novel treatment for neurofibromatosis type 1 tumors.,,The Nf1 mutant fly line was generated by CRISPR/Cas9 using the sgRNA line: y [1] sc[*] v [1] sev [21]; P{y[+t7.7] v[+t1.8] = TKO.GS01796}attP40,0.9,Accept,Experimental Usage,y [1] sc[*] v [1] sev [21]; P{y[+t7.7] v[+t1.8] = TKO.GS01796}attP40,,,Neurofibromatosis type 1,,,,,,
PMID:39129390,10.1002/1878-0261.13704,Inhibition of autophagy as a novel treatment for neurofibromatosis type 1 tumors.,,germline source of Cas9: y [1] M{w[+mC] = nos‐Cas9.P}ZH‐2A w[*] (Bloomington Stock #54591),0.9,Accept,Experimental Usage,y [1] M{w[+mC] = nos‐Cas9.P}ZH‐2A w[*],,,No known disease,,,,,,
PMID:39129390,10.1002/1878-0261.13704,Inhibition of autophagy as a novel treatment for neurofibromatosis type 1 tumors.,,dNf1 RNAi line: P{ KK101909 }VIE‐260B (VDRC #109637),0.9,Accept,Experimental Usage,P{ KK101909 }VIE‐260B,,,Neurofibromatosis type 1,,,,,,
PMID:39129390,10.1002/1878-0261.13704,Inhibition of autophagy as a novel treatment for neurofibromatosis type 1 tumors.,,subcutaneously into the right flank of male CD‐1 nude mice (Athymic Nude Mice obtained from Charles River (Crl:NU(NCr)‐Foxn1nu)),0.95,Accept,Experimental Usage,Crl:NU(NCr)‐Foxn1nu,CD-1,,No known disease,,,,,,
PMID:39129390,10.1002/1878-0261.13704,Inhibition of autophagy as a novel treatment for neurofibromatosis type 1 tumors.,,Toxicity studies were performed using CD‐1 mice and C57BL/6J Inbred Mice (JAX® Mice Strain),0.9,Accept,Experimental Usage,C57BL/6J,C57BL/6,C57BL/6J,No known disease,,,,,,
PMID:30571760,10.1371/journal.pone.0208835,Neurofibromin haploinsufficiency results in altered spermatogenesis in a mouse model of neurofibromatosis type 1.,,"The NF1 mouse model used in this study has been described elsewhere. Dsk9 is a missense mutation in the GTPase-activating protein related domain of neurofibromin. Nf1Dsk9/+ (subsequently referred to as ""Nf1+/-"") mice were maintained on a mixed (C3HeB/FeJ x C57bl/6) background.",0.95,Accept,Experimental Usage,Nf1Dsk9/+,C3HeB/FeJ x C57bl/6,,Neurofibromatosis type 1,,,,,,
PMID:29408605,10.1016/j.neuroscience.2018.01.054,Nf2 Mutation in Schwann Cells Delays Functional Neural Recovery Following Injury.,,"P0SchΔ39-121 transgenic mice were obtained from Riken Bioresource Center (Tsukuba, Japan). P0SchΔ39-121 heterozygous mice express a dominant negative form of merlin",0.95,Accept,Experimental Usage,P0SchΔ39-121,,,Neurofibromatosis type 2,,,,,,
PMID:29408605,10.1016/j.neuroscience.2018.01.054,Nf2 Mutation in Schwann Cells Delays Functional Neural Recovery Following Injury.,,"WT FVB mice were obtained from Jackson Labs (Bar Harbor, ME)",0.85,Accept,Experimental Usage,FVB,FVB,,No known disease,,,,,,
PMID:21111000,10.1016/j.jneumeth.2010.10.021,A novel imaging-compatible sciatic nerve schwannoma model.,,"implanted in 1 µl culture medium into the sciatic nerve of athymic mice (nu/nu, 5-week-old females; Cox 7 breeding facility, MGH)",0.9,Accept,Experimental Usage,nu/nu,,,No known disease,,,,,,
PMID:38931352,10.3390/ph17060685,PET Imaging of Neurofibromatosis Type 1 with a Fluorine-18 Labeled Tryptophan Radiotracer.,,"The triple mutant line from the vendor carries Trp53, Nf1, Suz12 mutations on chromosome 11 and develops tumors at approximately four months, which is similar to conditions found in human NF1 patients",0.95,Accept,Experimental Usage,"Trp53, Nf1, Suz12 triple mutant",,,Neurofibromatosis type 1,tumors,,,,,
PMID:39996452,10.1111/cns.70287,Cas9 Mouse Model of Skull Base Meningioma Driven by Combinational Gene Inactivation in Meningeal Cells.,,"Twenty mice of Rosa26‐LSL‐Cas9 knockin were purchased from Jackson Laboratory (Strain #:024857, USA) and successfully bred in our lab.",0.95,Accept,Experimental Usage,Rosa26-LSL-Cas9 knockin,,,No known disease,,,,,,
PMID:34935315,10.1117/1.JBO.26.12.125001,Analysis of muscle tissue in vivo using fiber-optic autofluorescence and diffuse reflectance spectroscopy.,,...two mouse models of genetic muscle disease: a type 1 neurofibromatosis (NF1) limb-mesenchyme knockout (Nf1Prx1-/-) and a muscular dystrophy mouse (mdx)...,0.95,Accept,Experimental Usage,Nf1Prx1-/-,C57BL/6,,Neurofibromatosis type 1,,,,,,
PMID:34935315,10.1117/1.JBO.26.12.125001,Analysis of muscle tissue in vivo using fiber-optic autofluorescence and diffuse reflectance spectroscopy.,,...two mouse models of genetic muscle disease: a type 1 neurofibromatosis (NF1) limb-mesenchyme knockout (Nf1Prx1-/-) and a muscular dystrophy mouse (mdx)...,0.9,Accept,Experimental Usage,mdx,C57BL/10,,No known disease,,,,,,
PMID:34935315,10.1117/1.JBO.26.12.125001,Analysis of muscle tissue in vivo using fiber-optic autofluorescence and diffuse reflectance spectroscopy.,,C57BL/6 mice (B6) and mice (NF1) were bred in-house at the Transgenic Facility at The Children's Hospital at Westmead...,0.85,Accept,Experimental Usage,C57BL/6,C57BL/6,,No known disease,,,,,,
PMID:34935315,10.1117/1.JBO.26.12.125001,Analysis of muscle tissue in vivo using fiber-optic autofluorescence and diffuse reflectance spectroscopy.,,...the NF1 mice bred from the Prx1-Cre transgenic mice and the Nf1flox/flox mice...,0.9,Accept,Experimental Usage,Nf1flox/flox,C57BL/6,,Neurofibromatosis type 1,,,,,,
PMID:34935315,10.1117/1.JBO.26.12.125001,Analysis of muscle tissue in vivo using fiber-optic autofluorescence and diffuse reflectance spectroscopy.,,...the NF1 mice bred from the Prx1-Cre transgenic mice and the Nf1flox/flox mice...,0.9,Accept,Experimental Usage,Prx1-Cre,C57BL/6,,No known disease,,,,,,
PMID:34935315,10.1117/1.JBO.26.12.125001,Analysis of muscle tissue in vivo using fiber-optic autofluorescence and diffuse reflectance spectroscopy.,,"The mdx mice (B10 mdx) were sourced from Australian Bioresources (ABR, Moss Vale). As these mice are on a C57BL/10 background...",0.9,Accept,Experimental Usage,B10 mdx,C57BL/10,,No known disease,,,,,,
PMID:8582272,10.1242/dev.121.11.3583,Neurofibromin-deficient fibroblasts fail to form perineurium in vitro.,,C57BL/6J mice in which one allele of the NF1 gene has been targeted were generated as described elsewhere,0.9,Accept,Experimental Usage,C57BL/6J,C57BL/6,C57BL/6J,Neurofibromatosis type 1,,,,,,
PMID:8582272,10.1242/dev.121.11.3583,Neurofibromin-deficient fibroblasts fail to form perineurium in vitro.,,male and female Nf1 (+/-) mice were mated for 12–16 hours,0.95,Accept,Experimental Usage,Nf1 (+/-),C57BL/6,,Neurofibromatosis type 1,,,,,,
PMID:8582272,10.1242/dev.121.11.3583,Neurofibromin-deficient fibroblasts fail to form perineurium in vitro.,,"In order to obtain Nf1 (-/-) embryos, male and female Nf1 (+/-) mice were mated",0.95,Accept,Experimental Usage,Nf1 (-/-),C57BL/6,,Neurofibromatosis type 1,,,,,,
PMID:33442015,10.1038/s41591-020-01193-6,Cabozantinib for neurofibromatosis type 1-related plexiform neurofibromas: a phase 2 trial.,,Genetically engineered Nf1flox/flox;PostnCre mice on a mixed C57BL/6 × 129/SV background were utilized for in vivo studies,0.95,Accept,Experimental Usage,Nf1flox/flox;PostnCre,C57BL/6 × 129/SV,,Neurofibromatosis type 1,Plexiform Neurofibroma,,,,,
PMID:29715273,10.1371/journal.pone.0196726,Neurofibromatosis type 2 tumor suppressor protein is expressed in oligodendrocytes and regulates cell proliferation and process formation.,,"NG2-EYFP mice, which carry a YFP fluorescent protein gene instead of a NG2 gene, are healthy and fertile and do not show any obvious phenotype",0.9,Accept,Experimental Usage,NG2-EYFP mice,,,No known disease,,,,,,
PMID:29715273,10.1371/journal.pone.0196726,Neurofibromatosis type 2 tumor suppressor protein is expressed in oligodendrocytes and regulates cell proliferation and process formation.,,"Mice for cell cultures were obtained from breedings of C57Bl6/J mice (Janvier Labs, France)",0.85,Accept,Experimental Usage,C57Bl6/J,C57BL/6,C57BL/6J,No known disease,,,,,,
PMID:24509877,10.1038/onc.2013.506,MAF mediates crosstalk between Ras-MAPK and mTOR signaling in NF1.,,injected subcutaneously into the right flanks of 6 to 8-week-old female athymic nude (nu/nu) mice (Harlan),0.9,Accept,Experimental Usage,nu/nu,,,No known disease,,,,,,
PMID:23328114,10.18632/oncotarget.793,Genomic imbalance of HMMR/RHAMM regulates the sensitivity and response of malignant peripheral nerve sheath tumour cells to aurora kinase inhibition.,,Four-month-old male NOD/SCID mice were anesthetized with isofluorane and orthotopically implanted with 1 mm3 piece of explant tumour,0.85,Accept,Experimental Usage,NOD/SCID,NOD/SCID,,No known disease,,,,,,
PMID:36322658,10.1126/sciadv.abo5442,Single-cell multiomics identifies clinically relevant mesenchymal stem-like cells and key regulators for MPNST malignancy.,,Mouse MPNST mice (Lats1/2-mut) were generated by crossing floxed Lats1Lats2 mice with Dhh-Cre mice (JAX 012929) to obtain Lats1/2-mut offspring,0.9,Accept,Experimental Usage,Lats1/2-mut,,,No known disease,Malignant Peripheral Nerve Sheath Tumor,,,,,
PMID:36322658,10.1126/sciadv.abo5442,Single-cell multiomics identifies clinically relevant mesenchymal stem-like cells and key regulators for MPNST malignancy.,,The NPE-mutant mice were generated by crossing NF1 fl/fl (JAX Nf1tm1Par/J) Tp53 fl/fl Eed fl/fl mice with Dhh-Cre mice,0.9,Accept,Experimental Usage,NF1 fl/fl Tp53 fl/fl Eed fl/fl;Dhh-Cre,,,Neurofibromatosis type 1,Malignant Peripheral Nerve Sheath Tumor,,,,,
PMID:36322658,10.1126/sciadv.abo5442,Single-cell multiomics identifies clinically relevant mesenchymal stem-like cells and key regulators for MPNST malignancy.,,"The reporter mice CAG-tdTomato (stock no. 007909), CAG-CAT-EGFP (ccGFP) (stock no. 024636) C57/Bl6;FVBN obtained from The Jackson Laboratory",0.85,Accept,Experimental Usage,CAG-tdTomato (stock no. 007909),C57BL/6,,No known disease,,,,,,
PMID:36322658,10.1126/sciadv.abo5442,Single-cell multiomics identifies clinically relevant mesenchymal stem-like cells and key regulators for MPNST malignancy.,,"The reporter mice CAG-tdTomato (stock no. 007909), CAG-CAT-EGFP (ccGFP) (stock no. 024636) C57/Bl6;FVBN obtained from The Jackson Laboratory",0.85,Accept,Experimental Usage,CAG-CAT-EGFP (stock no. 024636),C57BL/6,,No known disease,,,,,,
PMID:36322658,10.1126/sciadv.abo5442,Single-cell multiomics identifies clinically relevant mesenchymal stem-like cells and key regulators for MPNST malignancy.,,Female immunodeficient NBSGW (JAX 026622) mice of 6 to 8 weeks were used for allograft transplantations,0.85,Accept,Experimental Usage,NBSGW (JAX 026622),,,No known disease,,,,,,
PMID:36322658,10.1126/sciadv.abo5442,Single-cell multiomics identifies clinically relevant mesenchymal stem-like cells and key regulators for MPNST malignancy.,,Female athymic NCR nude mice of 6 to 8 weeks were used for xenograft transplantations,0.85,Accept,Experimental Usage,NCR nude,,,No known disease,,,,,,
PMID:21551250,10.1158/0008-5472.CAN-10-4577,Susceptible stages in Schwann cells for NF1-associated plexiform neurofibroma development.,,The NF1 flox/− mice are in a mixed genetic background of C57BL/6/Sv129 and have been described previously,0.9,Accept,Experimental Usage,NF1 flox/−,C57BL/6/Sv129,,Neurofibromatosis type 1,Plexiform Neurofibroma,,,,,
PMID:21551250,10.1158/0008-5472.CAN-10-4577,Susceptible stages in Schwann cells for NF1-associated plexiform neurofibroma development.,,"For conditional ablation of NF1, we used a tamoxifen-inducible Cre line, the PLPCre-ERT2 transgenic mice",0.85,Accept,Experimental Usage,PLPCre-ERT2,,,No known disease,,,,,,
PMID:21551250,10.1158/0008-5472.CAN-10-4577,Susceptible stages in Schwann cells for NF1-associated plexiform neurofibroma development.,,"The LacZ reporter mice, ROSA26R, were obtained from the Jackson Laboratories",0.85,Accept,Experimental Usage,ROSA26R,,,No known disease,,,,,,
PMID:37520682,10.1016/j.omtn.2023.06.018,Combining nonsense mutation suppression therapy with nonsense-mediated decay inhibition in neurofibromatosis type 1.,,Generation of NF1 NS/+ minipigs Generation of a swine nonsense mutation model of NF1 followed a similar strategy as previously described. Recurrent nonsense mutation R1947∗ NF1 is located within exon 41,0.95,Accept,Development,NF1 R1947/+,Ossabaw minipig,,Neurofibromatosis type 1,,,,,,
PMID:34040258,10.1038/s41586-021-03580-6,NF1 mutation drives neuronal activity-dependent initiation of optic glioma.,,"Nf1fl/fl, OPG Nf1fl/mut (Nf1+/−) and Nf1 (wild-type) mice were previously generated",0.9,Accept,Experimental Usage,Nf1fl/fl,C57BL/6,,Neurofibromatosis type 1,,,,,,
PMID:34040258,10.1038/s41586-021-03580-6,NF1 mutation drives neuronal activity-dependent initiation of optic glioma.,,"Nf1fl/fl, OPG Nf1fl/mut (Nf1+/−) and Nf1 (wild-type) mice were previously generated",0.9,Accept,Experimental Usage,OPG Nf1fl/mut (Nf1+/−),C57BL/6,,Neurofibromatosis type 1,Optic Nerve Glioma,,,,,
PMID:34040258,10.1038/s41586-021-03580-6,NF1 mutation drives neuronal activity-dependent initiation of optic glioma.,,"Thy1::ChR2-YFP (line 20) and Nlgn3KO mice were acquired from the Jackson Laboratory (012350 and 008394, respectively)",0.85,Accept,Experimental Usage,Thy1::ChR2-YFP (line 20),C57BL/6,,No known disease,,,,,,
PMID:34040258,10.1038/s41586-021-03580-6,NF1 mutation drives neuronal activity-dependent initiation of optic glioma.,,"Thy1::ChR2-YFP (line 20) and Nlgn3KO mice were acquired from the Jackson Laboratory (012350 and 008394, respectively)",0.85,Accept,Experimental Usage,Nlgn3KO,C57BL/6,,No known disease,,,,,,
PMID:21949590,10.2478/v10134-010-0025-8,ALTERED CALCIUM CURRENTS AND AXONAL GROWTH IN Nf1 HAPLOINSUFFICIENT MICE.,,Mice heterozygous for the Nf1 mutation on a background of C57BL/6J were originally developed by Dr. Tyler Jacks,0.95,Accept,Experimental Usage,Nf1+/- mice,C57BL/6,C57BL/6J,Neurofibromatosis type 1,,,,,,
PMID:21949590,10.2478/v10134-010-0025-8,ALTERED CALCIUM CURRENTS AND AXONAL GROWTH IN Nf1 HAPLOINSUFFICIENT MICE.,,Wildtype C57BL/6J and Nf1 mice littermates were housed and bred in the Indiana University Laboratory Animal Research Center,0.9,Accept,Experimental Usage,C57BL/6J,C57BL/6,C57BL/6J,No known disease,,,,,,
PMID:37164978,10.1038/s41467-023-38432-6,Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities.,,Immunodeficient NOD-Rag1 null IL2rg mice (The Jackson Laboratory) received approximately 3 million cells via subcutaneous flank injection,0.9,Accept,Experimental Usage,NOD-Rag1 null IL2rg,NOD,,No known disease,,,,,,
PMID:37164978,10.1038/s41467-023-38432-6,Multiplatform molecular profiling uncovers two subgroups of malignant peripheral nerve sheath tumors with distinct therapeutic vulnerabilities.,,non-obese diabetic severe combined immune deficiency spontaneous male mice (NOD-SCID-Prkdc scid) received 5 × 10^6 cells,0.9,Accept,Experimental Usage,NOD-SCID-Prkdc scid,NOD,,No known disease,,,,,,
PMID:25772366,10.1016/j.celrep.2015.02.041,Mouse low-grade gliomas contain cancer stem cells with unique molecular and functional properties.,,"Optic chiasm was microdissected from 3-month-old Nf1 flox/flox, Nf1 +/− and Nf1 +/− GFAP CKO mice to generate primary optic nerve neurospheres",0.9,Accept,Experimental Usage,Nf1 flox/flox,C57BL/6,,Neurofibromatosis type 1,Optic Nerve Glioma,,,,,
PMID:25772366,10.1016/j.celrep.2015.02.041,Mouse low-grade gliomas contain cancer stem cells with unique molecular and functional properties.,,"Optic chiasm was microdissected from 3-month-old Nf1 flox/flox, Nf1 +/− and Nf1 +/− GFAP CKO mice",0.9,Accept,Experimental Usage,Nf1 +/−,C57BL/6,,Neurofibromatosis type 1,Optic Nerve Glioma,,,,,
PMID:25772366,10.1016/j.celrep.2015.02.041,Mouse low-grade gliomas contain cancer stem cells with unique molecular and functional properties.,,"Optic chiasm was microdissected from 3-month-old Nf1 flox/flox, Nf1 +/− and Nf1 +/− GFAP CKO mice",0.9,Accept,Experimental Usage,Nf1 +/− GFAP CKO,C57BL/6,,Neurofibromatosis type 1,Optic Nerve Glioma,,,,,
PMID:25772366,10.1016/j.celrep.2015.02.041,Mouse low-grade gliomas contain cancer stem cells with unique molecular and functional properties.,,Athymic (B6.Cg/NTac-Foxn1nu NE10) mice were purchased from Taconic Laboratories,0.9,Accept,Experimental Usage,B6.Cg/NTac-Foxn1nu NE10,C57BL/6,,No known disease,,,,,,
PMID:23535903,10.1158/2159-8290.CD-13-0081,"Canonical Wnt/β-catenin signaling drives human schwann cell transformation, progression, and tumor maintenance.",,1.5 million cells in serum-free DMEM with 33% Matrigel Basement Membrane (BD Biosciences) were injected into the back flanks of athymic Foxn1 nu/nu mice (Charles Rivers Laboratory),0.85,Accept,Experimental Usage,Foxn1 nu/nu,,,No known disease,,,,,,
PMID:22901811,10.1016/j.cell.2012.06.034,ERK inhibition rescues defects in fate specification of Nf1-deficient neural progenitors and brain abnormalities.,,"The mutant mice ( Nf1 hGFAP CKO) used were of the genotypes, hGFAP-cre+; Nf1 flox/KO  and hGFAP-cre+; Nf1 flox/flox",0.95,Accept,Experimental Usage,Nf1 hGFAP CKO,"C57Bl6, 129Svj and FVB",,Neurofibromatosis type 1,,,,,,
PMID:22901811,10.1016/j.cell.2012.06.034,ERK inhibition rescues defects in fate specification of Nf1-deficient neural progenitors and brain abnormalities.,,Nestin-cre ER +; Nf1 flox/flox  (tamoxifen+) mice were used as mutants ( Nf1 NcreER CKO),0.9,Accept,Experimental Usage,Nf1 NcreER CKO,C57Bl6 and 129Svj,,Neurofibromatosis type 1,,,,,,
PMID:32383545,10.15252/embr.201949117,Hexokinase 2 displacement from mitochondria-associated membranes prompts Ca,,CT26 and 4T1 subcutaneous grafts in Balb/c mice,0.85,Accept,Experimental Usage,Balb/c,BALB/c,,No known disease,,,,,,
PMID:40590220,10.1172/JCI188932,A haploinsufficiency restoration strategy corrects neurobehavioral deficits in Nf1+/- mice.,,"Nf1 heterozygous (Nf1+/–, C57BL/6) mice have been previously described",0.95,Accept,Experimental Usage,Nf1+/–,C57BL/6,,Neurofibromatosis type 1,,,,,,
PMID:40590220,10.1172/JCI188932,A haploinsufficiency restoration strategy corrects neurobehavioral deficits in Nf1+/- mice.,,"Fbxw11 heterozygous (Fbxw11+/–, C57BL/6NTac) mice were from Knockout Mouse Project (KOMP)",0.9,Accept,Experimental Usage,Fbxw11tm1a(KOMP)Wtsi,C57BL/6NTac,,No known disease,,,,,,
PMID:40590220,10.1172/JCI188932,A haploinsufficiency restoration strategy corrects neurobehavioral deficits in Nf1+/- mice.,,Fbxw11fl/fl (exon 4 targeted) mice were generated from the Fbxw11tm1a(KOMP)Wtsi strain by FLP-FRT recombination,0.9,Accept,Experimental Usage,Fbxw11fl/fl,C57BL/6,,No known disease,,,,,,
PMID:21681782,10.1002/ajh.22035,Nf1 mutant mice with p19ARF gene loss develop accelerated hematopoietic disease resembling acute leukemia with a variable phenotype.,,Mice with the p19 mutation were a kind gift from Dr. Martine Roussel at St. Jude's Children's Research Hospital,0.9,Accept,Experimental Usage,p19 knockout,C57BL/6 × 129/Sv,,No known disease,,,,,,
PMID:21681782,10.1002/ajh.22035,Nf1 mutant mice with p19ARF gene loss develop accelerated hematopoietic disease resembling acute leukemia with a variable phenotype.,,"Mx1-Cre, Nf1 flox, and Nf1 fcr (Nf1 knockout) mice have been described previously",0.9,Accept,Experimental Usage,Mx1-Cre,C57BL/6 × C3H,,No known disease,,,,,,
PMID:21681782,10.1002/ajh.22035,Nf1 mutant mice with p19ARF gene loss develop accelerated hematopoietic disease resembling acute leukemia with a variable phenotype.,,"Mx1-Cre, Nf1 flox, and Nf1 fcr (Nf1 knockout) mice have been described previously",0.95,Accept,Experimental Usage,Nf1 flox,C57BL/6,,Neurofibromatosis type 1,,,,,,
PMID:21681782,10.1002/ajh.22035,Nf1 mutant mice with p19ARF gene loss develop accelerated hematopoietic disease resembling acute leukemia with a variable phenotype.,,"Mx1-Cre, Nf1 flox, and Nf1 fcr (Nf1 knockout) mice have been described previously",0.95,Accept,Experimental Usage,Nf1 fcr,C57BL/6,,Neurofibromatosis type 1,,,,,,
PMID:21681782,10.1002/ajh.22035,Nf1 mutant mice with p19ARF gene loss develop accelerated hematopoietic disease resembling acute leukemia with a variable phenotype.,,Recipient C57BL/6J × 129/Sv F1 mice were sublethally irradiated,0.85,Accept,Experimental Usage,C57BL/6J,C57BL/6,C57BL/6J,No known disease,,,,,,
PMID:21681782,10.1002/ajh.22035,Nf1 mutant mice with p19ARF gene loss develop accelerated hematopoietic disease resembling acute leukemia with a variable phenotype.,,recipient animals were generated by crossing 129/Sv mice to C57BL/6J mice,0.85,Accept,Experimental Usage,129/Sv,129/Sv,,No known disease,,,,,,
PMID:40191916,10.1093/g3journal/jkaf067,"The draft genome of the Wisconsin Miniature SwineTM, a valuable biomedical research tool.",,"The Wisconsin Miniature SwineTM (WMSTM) was developed to address these shortcomings. The WMSTM porcine model grows slower, reaching and maintaining human sizes at adulthood.",0.95,Accept,Development,Wisconsin Miniature SwineTM,,,No known disease,,,,,,
PMID:40191916,10.1093/g3journal/jkaf067,"The draft genome of the Wisconsin Miniature SwineTM, a valuable biomedical research tool.",,The WMSTM-WT and WMSTM-FH lines are housed at the University of Wisconsin Swine Research and Teaching Center,0.9,Accept,Experimental Usage,WMSTM-WT,,,No known disease,,,,,,
PMID:40191916,10.1093/g3journal/jkaf067,"The draft genome of the Wisconsin Miniature SwineTM, a valuable biomedical research tool.",,The WMSTM-WT and WMSTM-FH lines are housed at the University of Wisconsin Swine Research and Teaching Center,0.9,Accept,Experimental Usage,WMSTM-FH,,,No known disease,,,,,,
PMID:29438698,10.1016/j.ccell.2018.01.005,Programming of Schwann Cells by Lats1/2-TAZ/YAP Signaling Drives Malignant Peripheral Nerve Sheath Tumorigenesis.,,"Lats1 mice ( lox/lox Lats2 lox/lox Heallen et al., 2011 ), on a mixed C57/Bl6;129Sv;FVBN background, were crossed with Dhh -Cre",0.9,Accept,Experimental Usage,Lats1 lox/lox Lats2 lox/lox,C57/Bl6;129Sv;FVBN,,No known disease,,,,,,
PMID:29438698,10.1016/j.ccell.2018.01.005,Programming of Schwann Cells by Lats1/2-TAZ/YAP Signaling Drives Malignant Peripheral Nerve Sheath Tumorigenesis.,,"were crossed with Dhh -Cre ( Jaegle et al., 2003 ) mice or Plp1 -CreERT (Stock 005975) mice, both on a C57/Bl6 background",0.9,Accept,Experimental Usage,Dhh-Cre,C57/Bl6,,No known disease,,,,,,
PMID:29438698,10.1016/j.ccell.2018.01.005,Programming of Schwann Cells by Lats1/2-TAZ/YAP Signaling Drives Malignant Peripheral Nerve Sheath Tumorigenesis.,,"Plp1 -CreERT (Stock 005975) mice, both on a C57/Bl6 background to obtain Lats1 ;Cre lox/+ Lats2 lox/+ +/− mice",0.9,Accept,Experimental Usage,Plp1-CreERT (Stock 005975),C57/Bl6,,No known disease,,,,,,
PMID:29438698,10.1016/j.ccell.2018.01.005,Programming of Schwann Cells by Lats1/2-TAZ/YAP Signaling Drives Malignant Peripheral Nerve Sheath Tumorigenesis.,,"The reporter mice CAG-tdTomato (Stock 007909), CAG-CATEGFP (ccGFP) (Stock 024636) were obtained from the Jackson Laboratory",0.9,Accept,Experimental Usage,CAG-tdTomato (Stock 007909),,,No known disease,,,,,,
PMID:29438698,10.1016/j.ccell.2018.01.005,Programming of Schwann Cells by Lats1/2-TAZ/YAP Signaling Drives Malignant Peripheral Nerve Sheath Tumorigenesis.,,CAG-CATEGFP (ccGFP) (Stock 024636) were obtained from the Jackson Laboratory,0.9,Accept,Experimental Usage,CAG-CATEGFP (Stock 024636),,,No known disease,,,,,,
PMID:29438698,10.1016/j.ccell.2018.01.005,Programming of Schwann Cells by Lats1/2-TAZ/YAP Signaling Drives Malignant Peripheral Nerve Sheath Tumorigenesis.,,"Taz ( lox/lox Yap1 lox/lox Deng et al., 2017 ) mice, on a mixed C57/Bl6;129Sv;FVBN background",0.9,Accept,Experimental Usage,Taz lox/lox Yap1 lox/lox,C57/Bl6;129Sv;FVBN,,No known disease,,,,,,
PMID:29847659,10.1167/iovs.17-22588,Neurofibromin Deficiency Induces Endothelial Cell Proliferation and Retinal Neovascularization.,,"Nf1+/- mice were obtained from Tyler Jacks (Massachusetts Institute of Technology, Cambridge, MA, USA) and backcrossed 13 generations into the C57BL/6J strain.",0.9,Accept,Experimental Usage,Nf1+/-,C57BL/6J,,Neurofibromatosis type 1,,,,,,
PMID:29847659,10.1167/iovs.17-22588,Neurofibromin Deficiency Induces Endothelial Cell Proliferation and Retinal Neovascularization.,,"Nf1flox/flox mice were obtained from Luis Parada (University of Texas Southwestern Medical Center, Dallas, TX, USA) and maintained on C57BL/6J background.",0.9,Accept,Experimental Usage,Nf1flox/flox,C57BL/6J,,Neurofibromatosis type 1,,,,,,
PMID:29847659,10.1167/iovs.17-22588,Neurofibromin Deficiency Induces Endothelial Cell Proliferation and Retinal Neovascularization.,,"Tie2cre (4128) and VE-cadherin cre (VEcre, 6137) mice were purchased from The Jackson Laboratory (Bar Harbor, ME, USA)",0.85,Accept,Experimental Usage,Tie2cre,C57BL/6J,,No known disease,,,,,,
PMID:29847659,10.1167/iovs.17-22588,Neurofibromin Deficiency Induces Endothelial Cell Proliferation and Retinal Neovascularization.,,"Tie2cre (4128) and VE-cadherin cre (VEcre, 6137) mice were purchased from The Jackson Laboratory (Bar Harbor, ME, USA)",0.85,Accept,Experimental Usage,VE-cadherin cre,C57BL/6J,,No known disease,,,,,,
PMID:26822862,10.1038/srep20010,Capturing the wide variety of impaired fracture healing phenotypes in Neurofibromatosis Type 1 with eight key factors: a computational study.,,The geometrical domain of the computational model is deduced from the real callus geometry at three weeks post-fracture in a standardised femoral rat fracture model,0.75,Accept,Citation Only,standardised femoral rat fracture model,,,No known disease,,,,,,
PMID:36890585,10.1186/s40478-023-01525-w,Neurofibromatosis type 1-dependent alterations in mouse microglia function are not cell-intrinsic.,,heterozygous germline knockout mouse model of Neurofibromatosis type 1 (Nf1 ± mice),0.95,Accept,Experimental Usage,Nf1 ±,C57BL/6,,Neurofibromatosis type 1,,,,,,
PMID:36890585,10.1186/s40478-023-01525-w,Neurofibromatosis type 1-dependent alterations in mouse microglia function are not cell-intrinsic.,,bred onto a wild type or MacGreen (Csf1r-eGFP; [ 58 ] C57/BL6 background,0.9,Accept,Experimental Usage,MacGreen (Csf1r-eGFP),C57BL/6,,No known disease,,,,,,
PMID:36890585,10.1186/s40478-023-01525-w,Neurofibromatosis type 1-dependent alterations in mouse microglia function are not cell-intrinsic.,,CX3CR1-CreER [ 71 ] were intercrossed with Nf1 flox/flox,0.9,Accept,Experimental Usage,CX3CR1-CreER,,,No known disease,,,,,,
PMID:36890585,10.1186/s40478-023-01525-w,Neurofibromatosis type 1-dependent alterations in mouse microglia function are not cell-intrinsic.,,CX3CR1-CreER [ 71 ] were intercrossed with Nf1 flox/flox [ 1 ],0.95,Accept,Experimental Usage,Nf1 flox/flox,,,Neurofibromatosis type 1,,,,,,
PMID:36890585,10.1186/s40478-023-01525-w,Neurofibromatosis type 1-dependent alterations in mouse microglia function are not cell-intrinsic.,,intercrossed with Nf1 flox/flox [ 1 ] and R26R-EYFP mice [ 63 ],0.9,Accept,Experimental Usage,R26R-EYFP,,,No known disease,,,,,,
PMID:36890585,10.1186/s40478-023-01525-w,Neurofibromatosis type 1-dependent alterations in mouse microglia function are not cell-intrinsic.,,hGFAP-Cre +/+ were intercrossed with Nf1 flox/flox,0.9,Accept,Experimental Usage,hGFAP-Cre,,,No known disease,,,,,,
PMID:36730269,10.1371/journal.pone.0277305,Identification of therapeutic sensitivities in a spheroid drug combination screen of Neurofibromatosis Type I associated High Grade Gliomas.,,sporadically developed by the NPcis genetically engineered mouse model. The germline of these mice is heterozygous for Nf1 and Tp53; mutant alleles are located in cis,0.9,Accept,Experimental Usage,NPcis,,,Neurofibromatosis type 1,High Grade Glioma,,,,,
PMID:30274821,10.1016/j.ebiom.2018.09.042,Synergistic effect of Nutlin-3 combined with MG-132 on schwannoma cells through restoration of merlin and p53 tumour suppressors.,,RT4-D6P2T or HEI-193 cells were subcutaneously inoculated into the back of 4-week-old BALB/c nude mice (male),0.85,Accept,Experimental Usage,BALB/c nude,BALB/c,,No known disease,,,,,,
PMID:18632543,10.1001/jama.300.3.287,Effect of simvastatin on cognitive functioning in children with neurofibromatosis type 1: a randomized controlled trial.,,statin-mediated inhibition of 3-hydroxy-3-methylglutaryl coenzyme A reductase restores the cognitive deficits in an NF1 mouse model,0.85,Accept,Citation Only,Nf1 mice,,,Neurofibromatosis type 1,,,,,,
PMID:20554030,10.1016/j.jneuroim.2010.05.002,CXCL12 alone is insufficient for gliomagenesis in Nf1 mutant mice.,,"OPG mice (Nf1 flox/mut; GFAP-Cre, Nf1+/− GFAP CKO) mice were generated as previously described",0.95,Accept,Experimental Usage,"Nf1 flox/mut; GFAP-Cre, Nf1+/− GFAP CKO",C57Bl/6,,Neurofibromatosis type 1,Optic pathway glioma,,,,,
PMID:34065204,10.3390/ijms22105367,RABL6A Regulates Schwann Cell Senescence in an RB1-Dependent Manner.,,Mouse embryonic fibroblasts (MEFs) from wildtype and Rabl6m/m C57Bl/6N mice were isolated,0.9,Accept,Experimental Usage,Rabl6m/m C57Bl/6N,C57BL/6,C57BL/6N,No known disease,,,,,,
PMID:38000020,10.1126/sciadv.adg8876,CDK4/6 inhibition enhances SHP2 inhibitor efficacy and is dependent upon RB function in malignant peripheral nerve sheath tumors.,,Nonobese diabetic Rag gamma (NRG; no. 007799) female mice were purchased from the Jackson Laboratory,0.85,Accept,Experimental Usage,NRG,,,No known disease,,,,,,
PMID:34257279,10.1038/s41467-021-24505-x,Neurofibromin regulates metabolic rate via neuronal mechanisms in Drosophila.,,The Nf1 P1 mutation was backcrossed six generations into the w CS10 genetic background and w CS10 flies were used as controls.,0.9,Accept,Experimental Usage,Nf1 P1,w CS10,,Neurofibromatosis type 1,,,,,,
PMID:34257279,10.1038/s41467-021-24505-x,Neurofibromin regulates metabolic rate via neuronal mechanisms in Drosophila.,,The Nf1 P1 mutation was backcrossed six generations into the w CS10 genetic background and w CS10 flies were used as controls.,0.85,Accept,Experimental Usage,w CS10,,,No known disease,,,,,,
PMID:23685747,10.1038/ng.2641,Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis.,,Triple transgenic mice (Cnp-Cre; R26-lsl-SB11; T2/Onc15) undergo insertional mutagenesis in Schwann cells.,0.9,Accept,Experimental Usage,Cnp-Cre; R26-lsl-SB11; T2/Onc15,,,No known disease,Malignant Peripheral Nerve Sheath Tumor,,,,,
PMID:41444363,10.1038/s41598-025-32031-9,Focused ultrasound-mediated drug delivery of bevacizumab in treating NF2-related schwannomatosis in an animal model.,,The Postn-Cre transgenic and conditional Nf2flox/flox knocking alleles were obtained from the Conway and Clapp labs at Indiana University School of Medicine,0.95,Accept,Experimental Usage,Postn-Cre; Nf2flox/flox,FVB/NTac,,Neurofibromatosis type 2,schwannomas,,,,,
PMID:41444363,10.1038/s41598-025-32031-9,Focused ultrasound-mediated drug delivery of bevacizumab in treating NF2-related schwannomatosis in an animal model.,,conditional Nf2flox/flox knocking alleles were obtained from the Conway and Clapp labs,0.9,Accept,Experimental Usage,Nf2flox/flox,FVB/NTac,,Neurofibromatosis type 2,,,,,,
PMID:41444363,10.1038/s41598-025-32031-9,Focused ultrasound-mediated drug delivery of bevacizumab in treating NF2-related schwannomatosis in an animal model.,,The Postn-Cre transgenic and conditional Nf2flox/flox knocking alleles were obtained,0.9,Accept,Experimental Usage,Postn-Cre,FVB/NTac,,No known disease,,,,,,
PMID:41036607,10.1158/1535-7163.MCT-24-1053,Pharmacogenomic Synthetic Lethal Screens Reveal Hidden Vulnerabilities and New Therapeutic Approaches for Treatment of NF1-Associated Tumors.,,NF1-proficient and NF1-deficient engineered clones were injected into the flanks of 6- to 7-week-old athymic nude mice (RRID: JAX:002019),0.9,Accept,Experimental Usage,JAX:002019,,,No known disease,,,,,,
PMID:41036607,10.1158/1535-7163.MCT-24-1053,Pharmacogenomic Synthetic Lethal Screens Reveal Hidden Vulnerabilities and New Therapeutic Approaches for Treatment of NF1-Associated Tumors.,,"S462-TY cells (1.0 × 106) in 50% Matrigel (BD Biosciences) were injected subcutaneously into the flank of 6- to 7-week-old NOD-Rag1 null IL2rg null, NOD rag gamma, NOD-RG (NRG) mice (RRID: JAX:007799)",0.9,Accept,Experimental Usage,JAX:007799,,,No known disease,,,,,,
PMID:41036607,10.1158/1535-7163.MCT-24-1053,Pharmacogenomic Synthetic Lethal Screens Reveal Hidden Vulnerabilities and New Therapeutic Approaches for Treatment of NF1-Associated Tumors.,,"For the patient-derived xenograft (PDX) MPNST model, tumor tissue was implanted subcutaneously directly into NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ mice",0.85,Accept,Experimental Usage,NOD.Cg-Prkdcscid Il2rgtm1Wjl/SzJ,,,No known disease,,,,,,
PMID:41036607,10.1158/1535-7163.MCT-24-1053,Pharmacogenomic Synthetic Lethal Screens Reveal Hidden Vulnerabilities and New Therapeutic Approaches for Treatment of NF1-Associated Tumors.,,"The GEMM of high-grade PNSTs was generated as described previously. Dhh::Cre, Nf1fl/fl, Pten experimental class animals were randomized to a treatment or vehicle group",0.9,Accept,Experimental Usage,"Dhh::Cre, Nf1fl/fl, Pten",,,Neurofibromatosis type 1,Peripheral nerve sheath tumor,,,,,
PMID:30055648,10.1186/s13104-018-3630-0,Testing ATRA and MEK inhibitor PD0325901 effectiveness in a nude mouse model for human MPNST xenografts.,,"Balb/c Nude (Balb/cAnNRj-Foxn1nu/Foxn1nu, Janvier), Foxn1 (Nu/Nu) Nude (Crl:NU-Foxn1nu, Charles River)",0.95,Accept,Experimental Usage,Balb/cAnNRj-Foxn1nu/Foxn1nu,BALB/c,,No known disease,,,,,,
PMID:30055648,10.1186/s13104-018-3630-0,Testing ATRA and MEK inhibitor PD0325901 effectiveness in a nude mouse model for human MPNST xenografts.,,"Foxn1 (Nu/Nu) Nude (Crl:NU-Foxn1nu, Charles River), SHO ® (SCID Hairless Outbred, Crl:SHO-PrkdcscidHrhr, Charles River)",0.95,Accept,Experimental Usage,Crl:NU-Foxn1nu,,,No known disease,,,,,,
PMID:30055648,10.1186/s13104-018-3630-0,Testing ATRA and MEK inhibitor PD0325901 effectiveness in a nude mouse model for human MPNST xenografts.,,"SHO ® (SCID Hairless Outbred, Crl:SHO-PrkdcscidHrhr, Charles River) and Shorn (ShrN NOD SCID, NOD.Cg-PrkdcscidHrhr/NCrHsd, Harlan)",0.95,Accept,Experimental Usage,Crl:SHO-PrkdcscidHrhr,,,No known disease,,,,,,
PMID:30055648,10.1186/s13104-018-3630-0,Testing ATRA and MEK inhibitor PD0325901 effectiveness in a nude mouse model for human MPNST xenografts.,,"Shorn (ShrN NOD SCID, NOD.Cg-PrkdcscidHrhr/NCrHsd, Harlan) mice were scheduled for xenotransplantations",0.95,Accept,Experimental Usage,NOD.Cg-PrkdcscidHrhr/NCrHsd,NOD,,No known disease,,,,,,
PMID:18451155,10.1158/0008-5472.CAN-07-6867,Pten haploinsufficiency accelerates formation of high-grade astrocytomas.,,"To generate Mut3 to Mut6 mice (see Fig. 1A for genetic configurations), we crossed Mut3 (8) or Mut4 males with wild-type (wt), loxP-Pten (Pten f hereafter; ref. 27)",0.85,Accept,Experimental Usage,Mut3,"C57/BL6, Sv129, and B6/CBA",,Neurofibromatosis type 1,astrocytomas,,,,,
PMID:18451155,10.1158/0008-5472.CAN-07-6867,Pten haploinsufficiency accelerates formation of high-grade astrocytomas.,,"To generate Mut3 to Mut6 mice (see Fig. 1A for genetic configurations), we crossed Mut3 (8) or Mut4 males with wild-type (wt), loxP-Pten (Pten f hereafter; ref. 27)",0.85,Accept,Experimental Usage,Mut4,"C57/BL6, Sv129, and B6/CBA",,Neurofibromatosis type 1,astrocytomas,,,,,
PMID:18451155,10.1158/0008-5472.CAN-07-6867,Pten haploinsufficiency accelerates formation of high-grade astrocytomas.,,"we crossed Mut3 (8) or Mut4 males with wild-type (wt), loxP-Pten (Pten f hereafter; ref. 27), p53 f (28), or p53 f ; Pten f females",0.9,Accept,Experimental Usage,loxP-Pten (Pten f),,,No known disease,,,,,,
PMID:18451155,10.1158/0008-5472.CAN-07-6867,Pten haploinsufficiency accelerates formation of high-grade astrocytomas.,,"we crossed Mut3 (8) or Mut4 males with wild-type (wt), loxP-Pten (Pten f hereafter; ref. 27), p53 f (28), or p53 f ; Pten f females",0.9,Accept,Experimental Usage,p53 f,,,No known disease,,,,,,
PMID:26883872,10.1016/j.jprot.2016.02.004,3-D imaging mass spectrometry of protein distributions in mouse Neurofibromatosis 1 (NF1)-associated optic glioma.,,Nf1^flox/flox;GFAP-Cre mice (OPG mice) were generated as previously described. All mice were maintained on a C57BL/6 background,0.9,Accept,Experimental Usage,Nf1^flox/flox;GFAP-Cre,C57BL/6,,Neurofibromatosis type 1,Optic Nerve Glioma,,,,,
PMID:35511749,10.1158/1535-7163.MCT-21-0947,A High-Throughput Screening Platform Identifies Novel Combination Treatments for Malignant Peripheral Nerve Sheath Tumors.,,"using athymic nude six-week-old male mice, in which no tumor was engrafted",0.85,Accept,Experimental Usage,athymic nude,,,No known disease,,,,,,
PMID:28029918,10.1056/NEJMoa1605943,Activity of Selumetinib in Neurofibromatosis Type 1-Related Plexiform Neurofibromas.,,Selumetinib was evaluated in the DhhCre;Nf1fl/fl genetically engineered mouse model of neurofibroma,0.95,Accept,Experimental Usage,DhhCre;Nf1fl/fl,,,Neurofibromatosis type 1,neurofibroma,,,,,
PMID:18636037,10.1097/MAO.0b013e31817f7398,The ErbB inhibitors trastuzumab and erlotinib inhibit growth of vestibular schwannoma xenografts in nude mice: a preliminary study.,,"Xenografts were developed in male athymic Ncr Nu/Nu mice (National Cancer Institute, NIH, Bethesda, MD)",0.9,Accept,Experimental Usage,athymic Ncr Nu/Nu,,,No known disease,,,,,,
PMID:25026211,10.1016/j.ccr.2014.05.001,Merlin/NF2 loss-driven tumorigenesis linked to CRL4(DCAF1)-mediated inhibition of the hippo pathway kinases Lats1 and 2 in the nucleus.,,1×10 6 FC-1801 cells were suspended in Ca/Mg-free PBS and injected subcutaneously into the right flank of nude mice.,0.8,Accept,Experimental Usage,nude mice,,,No known disease,,,,,,
PMID:21072183,10.1371/journal.pone.0013791,p21-Activated kinases are required for transformation in a cell-based model of neurofibromatosis type 2.,,2×10^6 cells were injected subcutaneously into flanks of 5-week old nude mice (BALB/c nu/nu),0.95,Accept,Experimental Usage,BALB/c nu/nu,BALB/c,,No known disease,,,,,,
PMID:33032988,10.1158/0008-5472.CAN-20-1365,Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors.,,"Athymic nude (# 002019) and NOD scid gamma (NSG, # 005557) female mice were purchased from the Jackson Laboratory",0.85,Accept,Experimental Usage,#002019,,,No known disease,,,,,,
PMID:33032988,10.1158/0008-5472.CAN-20-1365,Combined Inhibition of SHP2 and MEK Is Effective in Models of NF1-Deficient Malignant Peripheral Nerve Sheath Tumors.,,"Athymic nude (# 002019) and NOD scid gamma (NSG, # 005557) female mice were purchased from the Jackson Laboratory",0.85,Accept,Experimental Usage,#005557,NOD,,No known disease,,,,,,
PMID:24465906,10.1371/journal.pone.0086115,"Multiscale, converging defects of macro-porosity, microstructure and matrix mineralization impact long bone fragility in NF1.",,"we analyzed two conditional mouse models, Nf1Prx1 (limb knock-out) and Nf1Col1 (osteoblast specific knock-out)",0.95,Accept,Experimental Usage,Nf1Prx1,,,Neurofibromatosis type 1,limb knock-out,,,,,
PMID:24465906,10.1371/journal.pone.0086115,"Multiscale, converging defects of macro-porosity, microstructure and matrix mineralization impact long bone fragility in NF1.",,"we analyzed two conditional mouse models, Nf1Prx1 (limb knock-out) and Nf1Col1 (osteoblast specific knock-out)",0.95,Accept,Experimental Usage,Nf1Col1,,,Neurofibromatosis type 1,osteoblast specific knock-out,,,,,
PMID:26904939,10.1016/j.celrep.2016.01.074,Insertional Mutagenesis Identifies a STAT3/Arid1b/β-catenin Pathway Driving Neurofibroma Initiation.,,Genetic deletion of Stat3 in Schwann cell progenitors (SCPs) and Schwann cells (SCs) prevents neurofibroma formation,0.9,Accept,Experimental Usage,Nf1(fl/fl);DhhCre,,,Neurofibromatosis type 1,Neurofibroma,,,,,
PMID:26904939,10.1016/j.celrep.2016.01.074,Insertional Mutagenesis Identifies a STAT3/Arid1b/β-catenin Pathway Driving Neurofibroma Initiation.,,Knockdown of Arid1b or Gsk3β in Stat3(fl/fl);Nf1(fl/fl);DhhCre SCPs rescues neurofibroma formation after in vivo transplantation,0.9,Accept,Experimental Usage,Stat3(fl/fl);Nf1(fl/fl);DhhCre,,,Neurofibromatosis type 1,Neurofibroma,,,,,
PMID:26904939,10.1016/j.celrep.2016.01.074,Insertional Mutagenesis Identifies a STAT3/Arid1b/β-catenin Pathway Driving Neurofibroma Initiation.,,"We injected 5×10^5 mouse sphere cells/injection subcutaneously into athymic female nude mice (Harlan, Indianapolis, IN)",0.85,Accept,Experimental Usage,athymic female nude mice,,,No known disease,,,,,,
PMID:34010628,10.1016/j.stem.2021.04.029,Stem-like cells drive NF1-associated MPNST functional heterogeneity and tumor progression.,,SKPs were isolated as previously reported from neonatal Nf1f/f;Trp53f/f;Nes-TK mice within 2 weeks of age,0.9,Accept,Experimental Usage,Nf1f/f;Trp53f/f;Nes-TK,,,Neurofibromatosis type 1,Malignant Peripheral Nerve Sheath Tumor,,,,,
PMID:34010628,10.1016/j.stem.2021.04.029,Stem-like cells drive NF1-associated MPNST functional heterogeneity and tumor progression.,,BC and DRG were harvested from the E13.5 embryos as described from Nf1f/f;Trp53f/f;CGD mice,0.9,Accept,Experimental Usage,Nf1f/f;Trp53f/f;CGD,,,Neurofibromatosis type 1,Malignant Peripheral Nerve Sheath Tumor,,,,,
PMID:34010628,10.1016/j.stem.2021.04.029,Stem-like cells drive NF1-associated MPNST functional heterogeneity and tumor progression.,,"A spontaneous MPNST GEMM, cisNP, was previously described (Vogel et al., 1999)",0.85,Accept,Experimental Usage,cisNP,,,Neurofibromatosis type 1,Malignant Peripheral Nerve Sheath Tumor,,,,,
PMID:18242513,10.1016/j.ccr.2008.01.003,The loss of Nf1 transiently promotes self-renewal but not tumorigenesis by neural crest stem cells.,,"Several Nf1 alleles were used in these studies including Nf1 (germline mutant) mice (− Jacks et al., 1994)",0.9,Accept,Experimental Usage,Nf1-/-,,,Neurofibromatosis type 1,,,,,,
PMID:18242513,10.1016/j.ccr.2008.01.003,The loss of Nf1 transiently promotes self-renewal but not tumorigenesis by neural crest stem cells.,,"Nf1 mice for conditional deletion (fl Zhu et al., 2001)",0.9,Accept,Experimental Usage,Nf1fl,,,Neurofibromatosis type 1,,,,,,
PMID:18242513,10.1016/j.ccr.2008.01.003,The loss of Nf1 transiently promotes self-renewal but not tumorigenesis by neural crest stem cells.,,"Nf1/p53 cis mutant mice (− Cichowski et al., 1999)",0.9,Accept,Experimental Usage,Nf1/p53-/-,,,Neurofibromatosis type 1,Malignant peripheral nerve sheath tumors,,,,,
PMID:18242513,10.1016/j.ccr.2008.01.003,The loss of Nf1 transiently promotes self-renewal but not tumorigenesis by neural crest stem cells.,,"For conditional deletion of Nf1 we used Wnt-1-Cre (+ Danielian et al., 1998)",0.9,Accept,Experimental Usage,Wnt-1-Cre+,,,No known disease,,,,,,
PMID:18242513,10.1016/j.ccr.2008.01.003,The loss of Nf1 transiently promotes self-renewal but not tumorigenesis by neural crest stem cells.,,"3.9Periostin-Cre (+ Lindsley et al., 2007)",0.9,Accept,Experimental Usage,3.9Periostin-Cre+,,,No known disease,,,,,,
PMID:18242513,10.1016/j.ccr.2008.01.003,The loss of Nf1 transiently promotes self-renewal but not tumorigenesis by neural crest stem cells.,,"P0a-Cre (+ Giovannini et al., 2000) mice",0.9,Accept,Experimental Usage,P0a-Cre+,,,No known disease,,,,,,
PMID:18242513,10.1016/j.ccr.2008.01.003,The loss of Nf1 transiently promotes self-renewal but not tumorigenesis by neural crest stem cells.,,"Compound mutant mice were generated by mating Nf1 mice with +/− Ink4a mice (−/− Sharpless et al., 2001)",0.9,Accept,Experimental Usage,Ink4a-/-,,,No known disease,,,,,,
PMID:18242513,10.1016/j.ccr.2008.01.003,The loss of Nf1 transiently promotes self-renewal but not tumorigenesis by neural crest stem cells.,,"Ink4aArf mice (−/− Serrano et al., 1996)",0.9,Accept,Experimental Usage,Ink4aArf-/-,,,No known disease,,,,,,
PMID:24386979,10.1186/1471-2407-14-6,"Modulation of Ras signaling alters the toxicity of hydroquinone, a benzene metabolite and component of cigarette smoke.",,"Mx1-Cre, Nf1 flox/flox mice (129SV × C57BL/6 J) were generated and somatic Nf1 inactivation was induced as described elsewhere",0.95,Accept,Experimental Usage,"Mx1-Cre, Nf1 flox/flox",129SV × C57BL/6 J,,Neurofibromatosis type 1,,,,,,
PMID:21216928,10.1158/1535-7163.MCT-10-0654,Interpreting mammalian target of rapamycin and cell growth inhibition in a genetically engineered mouse model of Nf1-deficient astrocytes.,,Five-six week-old Nf1 GFAP CKO mice (Nf1 flox/flox; GFAP-Cre) were used. These mice lack Nf1 gene expression in GFAP+ (glial) cells,0.95,Accept,Experimental Usage,Nf1 flox/flox; GFAP-Cre,C57BL/6,,Neurofibromatosis type 1,Optic glioma,,,,,
PMID:25917366,10.1038/mp.2015.48,HCN channels are a novel therapeutic target for cognitive dysfunction in Neurofibromatosis type 1.,,Homozygous 9a−/9a− Nf1 mutants and wild-type (WT) littermates in the hybrid B6/129T2 background,0.9,Accept,Experimental Usage,9a−/9a− Nf1,B6/129T2 hybrid,,Neurofibromatosis type 1,,,,,,
PMID:25917366,10.1038/mp.2015.48,HCN channels are a novel therapeutic target for cognitive dysfunction in Neurofibromatosis type 1.,,crossing the obtained F1 mutant mice with each other to get homozygous 9a−/9a+ Nf1 mutants,0.9,Accept,Experimental Usage,9a−/9a+ Nf1,B6/129T2 hybrid,,Neurofibromatosis type 1,,,,,,
PMID:25917366,10.1038/mp.2015.48,HCN channels are a novel therapeutic target for cognitive dysfunction in Neurofibromatosis type 1.,,Experimental mice were obtained by crossing Nf1 mice (in C57BL/6JOlaHsd background),0.85,Accept,Experimental Usage,C57BL/6JOlaHsd,C57BL/6,C57BL/6JOlaHsd,No known disease,,,,,,
PMID:25917366,10.1038/mp.2015.48,HCN channels are a novel therapeutic target for cognitive dysfunction in Neurofibromatosis type 1.,,"with 129T2/SvEmsJ (Jackson Laboratories, Bar Harbor, ME, USA)",0.85,Accept,Experimental Usage,129T2/SvEmsJ,129T2,,No known disease,,,,,,
PMID:25917366,10.1038/mp.2015.48,HCN channels are a novel therapeutic target for cognitive dysfunction in Neurofibromatosis type 1.,,+/− H-Ras mice in C57BL/6JOlaHsd background were obtained by crossing heterozygous G12V H-Ras mice,0.9,Accept,Experimental Usage,G12V H-Ras,C57BL/6,C57BL/6JOlaHsd,No known disease,,,,,,
PMID:38714355,10.1158/1535-7163.MCT-23-0510,MEK Inhibition Enhances the Antitumor Effect of Radiotherapy in NF1-Deficient Glioblastoma.,,NOD scid gamma (NSG) female and male mice were purchased from Johns Hopkins University Animal Resources Core,0.9,Accept,Experimental Usage,NOD scid gamma,NOD,,No known disease,,,,,,
PMID:33934112,10.1038/s41419-021-03716-6,HIF1α-dependent induction of the mitochondrial chaperone TRAP1 regulates bioenergetic adaptations to hypoxia.,,The male Zebrafish reporter line for HIF1α Tg(4xhre-tata:eGFP)ia was outcrossed with female wild-type Zebrafish,0.85,Accept,Experimental Usage,Tg(4xhre-tata:eGFP)ia,,,No known disease,,,,,,
PMID:33934112,10.1038/s41419-021-03716-6,HIF1α-dependent induction of the mitochondrial chaperone TRAP1 regulates bioenergetic adaptations to hypoxia.,,"generating the final transgenic line Tg(ptf1a:Gal4)/UAS:eGFPKRAS G12D, as described",0.85,Accept,Experimental Usage,Tg(ptf1a:Gal4)/UAS:eGFPKRAS G12D,,,No known disease,pancreatic adenocarcinoma,,,,,
PMID:25340526,10.1371/journal.pone.0107760,Nilotinib is more potent than imatinib for treating plexiform neurofibroma in vitro and in vivo.,,"Athymic nude mice (female, nu/nu Balb/c, 6 weeks, 20 g) were obtained from Charles River Laboratories (Sulzfeld, Germany).",0.9,Accept,Experimental Usage,nu/nu Balb/c,BALB/c,,No known disease,,,,,,
PMID:29787563,10.1371/journal.pone.0190001,Graph complexity analysis identifies an ETV5 tumor-specific network in human and murine low-grade glioma.,,"Nf1flox/flox Nf1flox/null; GFAP-Cre (OPG-1), Nf1flox/R681*; GFAP-Cre (OPG-2), Nf1flox/null; Ptenflox/wt; GFAP-Cre (OPG-3), and Nf1flox/null; Olig2-Cre (OPG-4) mice",0.9,Accept,Experimental Usage,Nf1flox/flox,C57Bl/6,,Neurofibromatosis type 1,,,,,,
PMID:29787563,10.1371/journal.pone.0190001,Graph complexity analysis identifies an ETV5 tumor-specific network in human and murine low-grade glioma.,,"Nf1flox/null; GFAP-Cre (OPG-1), Nf1flox/R681*; GFAP-Cre (OPG-2), Nf1flox/null; Ptenflox/wt; GFAP-Cre (OPG-3), and Nf1flox/null; Olig2-Cre (OPG-4) mice",0.9,Accept,Experimental Usage,Nf1flox/null; GFAP-Cre,C57Bl/6,,Neurofibromatosis type 1,Optic glioma,,,,,
PMID:29787563,10.1371/journal.pone.0190001,Graph complexity analysis identifies an ETV5 tumor-specific network in human and murine low-grade glioma.,,"Nf1flox/null; GFAP-Cre (OPG-1), Nf1flox/R681*; GFAP-Cre (OPG-2), Nf1flox/null; Ptenflox/wt; GFAP-Cre (OPG-3), and Nf1flox/null; Olig2-Cre (OPG-4) mice",0.9,Accept,Experimental Usage,Nf1flox/R681*; GFAP-Cre,C57Bl/6,,Neurofibromatosis type 1,Optic glioma,,,,,
PMID:29787563,10.1371/journal.pone.0190001,Graph complexity analysis identifies an ETV5 tumor-specific network in human and murine low-grade glioma.,,"Nf1flox/null; GFAP-Cre (OPG-1), Nf1flox/R681*; GFAP-Cre (OPG-2), Nf1flox/null; Ptenflox/wt; GFAP-Cre (OPG-3), and Nf1flox/null; Olig2-Cre (OPG-4) mice",0.9,Accept,Experimental Usage,Nf1flox/null; Ptenflox/wt; GFAP-Cre,C57Bl/6,,Neurofibromatosis type 1,Optic glioma,,,,,
PMID:29787563,10.1371/journal.pone.0190001,Graph complexity analysis identifies an ETV5 tumor-specific network in human and murine low-grade glioma.,,"Nf1flox/null; GFAP-Cre (OPG-1), Nf1flox/R681*; GFAP-Cre (OPG-2), Nf1flox/null; Ptenflox/wt; GFAP-Cre (OPG-3), and Nf1flox/null; Olig2-Cre (OPG-4) mice",0.9,Accept,Experimental Usage,Nf1flox/null; Olig2-Cre,C57Bl/6,,Neurofibromatosis type 1,Optic glioma,,,,,
PMID:28256556,10.1038/srep43315,An inflammatory gene signature distinguishes neurofibroma Schwann cells and macrophages from cells in the normal peripheral nervous system.,,"by in-house breeding to Nf1 and fl/ + DhhCre to obtain Nf1 fl/fl ;DhhCre or Nf1 mice, as previously described",0.95,Accept,Experimental Usage,Nf1fl/fl;DhhCre,C57Bl/6,,Neurofibromatosis type 1,Neurofibroma,,,,,
PMID:40684195,10.1186/s40478-025-02075-z,Unraveling the development of cutaneous neurofibromas in neurofibromatosis type 1.,,"The following mouse lines were used and genotyped as described in the original publications: Prss56Cre/Cre, R26tdTom/tdTom; Prss56Cre/Cre",0.9,Accept,Experimental Usage,Prss56Cre/Cre,,,No known disease,,,,,,
PMID:40684195,10.1186/s40478-025-02075-z,Unraveling the development of cutaneous neurofibromas in neurofibromatosis type 1.,,"The following mouse lines were used and genotyped as described in the original publications: Prss56Cre/Cre, R26tdTom/tdTom; Prss56Cre/Cre",0.9,Accept,Experimental Usage,R26tdTom/tdTom,,,No known disease,,,,,,
PMID:40684195,10.1186/s40478-025-02075-z,Unraveling the development of cutaneous neurofibromas in neurofibromatosis type 1.,,"R26tdTom/tdTom, Nf1flox/flox; Nf1flox/flox; Nf1+/−; and B6D2F1",0.95,Accept,Experimental Usage,Nf1flox/flox,,,Neurofibromatosis type 1,,,,,,
PMID:40684195,10.1186/s40478-025-02075-z,Unraveling the development of cutaneous neurofibromas in neurofibromatosis type 1.,,"R26tdTom/tdTom, Nf1flox/flox; Nf1flox/flox; Nf1+/−; and B6D2F1",0.95,Accept,Experimental Usage,Nf1+/−,,,Neurofibromatosis type 1,,,,,,
PMID:40684195,10.1186/s40478-025-02075-z,Unraveling the development of cutaneous neurofibromas in neurofibromatosis type 1.,,Nf1+/−; and B6D2F1 (https://janvier-labs.com/en/fiche_produit/b6d2f1-mouse/),0.9,Accept,Experimental Usage,B6D2F1,B6D2F1,,No known disease,,,,,,
PMID:35393510,10.1038/s41418-022-00991-4,Tumor growth of neurofibromin-deficient cells is driven by decreased respiration and hampered by NAD,,cisMPNST cells were derived from spontaneous MPNSTs arising in cis Nf1+/−;P53+/− mice,0.9,Accept,Experimental Usage,cis Nf1+/−;P53+/−,,,Neurofibromatosis type 1,Malignant Peripheral Nerve Sheath Tumor,,,,,
PMID:35393510,10.1038/s41418-022-00991-4,Tumor growth of neurofibromin-deficient cells is driven by decreased respiration and hampered by NAD,,"Experiments were performed in 8-week-old nude female mice (Charles River, Wilmington, MA)",0.9,Accept,Experimental Usage,nude,,,No known disease,,,,,,
PMID:17924978,10.1111/j.1750-3639.2007.00105.x,Natural history of meningioma development in mice reveals: a synergy of Nf2 and p16(Ink4a) mutations.,,"To obtain Nf2 flox2/flox2 ;p16 Ink4a*/* mice, Nf2 flox2/flox2 mice (4) on the FVB/N background were bred to p16 Ink4a*/* mice",0.9,Accept,Experimental Usage,Nf2 flox2/flox2,FVB/N,,Neurofibromatosis type 2,Meningioma,,,,,
PMID:17924978,10.1111/j.1750-3639.2007.00105.x,Natural history of meningioma development in mice reveals: a synergy of Nf2 and p16(Ink4a) mutations.,,Nf2 flox2/flox2 mice (4) on the FVB/N background were bred to p16 Ink4a*/* mice (11) on a FVB/N/129Ola mixed background,0.9,Accept,Experimental Usage,p16 Ink4a*/*,FVB/N/129Ola mixed,,No known disease,,,,,,
PMID:17924978,10.1111/j.1750-3639.2007.00105.x,Natural history of meningioma development in mice reveals: a synergy of Nf2 and p16(Ink4a) mutations.,,"To obtain Nf2 flox2/flox2 ;p16 Ink4a*/* mice, Nf2 flox2/flox2 mice (4) on the FVB/N background were bred to p16 Ink4a*/* mice",0.95,Accept,Experimental Usage,Nf2 flox2/flox2 ;p16 Ink4a*/*,FVB/N mixed strain,,Neurofibromatosis type 2,Meningioma,,,,,
PMID:18483311,10.1158/1535-7163.MCT-07-2335,Effective in vivo targeting of the mammalian target of rapamycin pathway in malignant peripheral nerve sheath tumors.,,Athymic nu/nu mice were anesthetized in isoflurane and injected s.c. with 10^6 STS26T cells in the left flank,0.85,Accept,Experimental Usage,nu/nu,,,No known disease,,,,,,
PMID:37140985,10.1172/JCI168227,Basement membrane proteins in extracellular matrix characterize NF1 neurofibroma development and response to MEK inhibitor.,,The H7;Nf1mut mice have been described previously (10). Mice were maintained in a clean mouse facility...,0.9,Accept,Experimental Usage,H7;Nf1mut,,,Neurofibromatosis type 1,Plexiform Neurofibroma,,,,,
PMID:20551058,10.1158/0008-5472.CAN-09-3769,Cyclic AMP suppression is sufficient to induce gliomagenesis in a mouse model of neurofibromatosis-1.,,"Wild type ( Nf1 ), Tumor Progenitor ( flox/flox Nf1 ; GFAP-Cre), and OPG ( flox/flox Nf1 ; GFAP-Cre) mice were generated as previously described",0.9,Accept,Experimental Usage,Nf1^flox/flox;GFAP-Cre,,,Neurofibromatosis type 1,Optic Nerve Glioma,,,,,
PMID:20551058,10.1158/0008-5472.CAN-09-3769,Cyclic AMP suppression is sufficient to induce gliomagenesis in a mouse model of neurofibromatosis-1.,,"Wild type ( Nf1 ), Tumor Progenitor ( flox/flox Nf1 ; GFAP-Cre), and OPG ( flox/flox Nf1 ; GFAP-Cre) mice were generated as previously described",0.9,Accept,Experimental Usage,Nf1^flox/mut;GFAP-Cre,,,Neurofibromatosis type 1,,,,,,
PMID:41023593,10.1186/s10020-025-01353-9,Selective inhibition of BRAF and CRAF sensitizes NF1-deficient malignant peripheral nerve sheath tumors to MEK inhibitors.,,"6- to 8-week-old NSG (NOD.Cg-Prkdc scid Il2rg tm1Wjl /SzJ, strain #:005557, Jackson Laboratory or Johns Hopkins Oncology Animal Facility) and SCID female mice were used for in vivo efficacy studies",0.95,Accept,Experimental Usage,NOD.Cg-Prkdc scid Il2rg tm1Wjl /SzJ,NOD,,No known disease,,,,,,
PMID:41023593,10.1186/s10020-025-01353-9,Selective inhibition of BRAF and CRAF sensitizes NF1-deficient malignant peripheral nerve sheath tumors to MEK inhibitors.,,"NSG and SCID (C.B-17/IcrHsd-Prkdc scid , Envigo) female mice were used for in vivo efficacy studies",0.9,Accept,Experimental Usage,C.B-17/IcrHsd-Prkdc scid,C.B-17,,No known disease,,,,,,
PMID:38127282,10.1158/1078-0432.CCR-23-2548,Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression.,,RNAseq data from murine peripheral nerve sheath tumors arising in DhhCre mice harboring Nf1-floxed alleles and Ink4a/Arf heterozygosity,0.85,Accept,Experimental Usage,DhhCre,,,Neurofibromatosis type 1,Peripheral nerve sheath tumors,,,,,
PMID:38127282,10.1158/1078-0432.CCR-23-2548,Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression.,,RNAseq data from Nf1flox/flox;PostnCre+ and Nf1flox/flox;Arf flox/flox;PostnCre+ mice,0.85,Accept,Experimental Usage,Nf1flox/flox;PostnCre+,,,Neurofibromatosis type 1,,,,,,
PMID:38127282,10.1158/1078-0432.CCR-23-2548,Spatial Gene-Expression Profiling Unveils Immuno-oncogenic Programs of NF1-Associated Peripheral Nerve Sheath Tumor Progression.,,RNAseq data from Nf1flox/flox;PostnCre+ and Nf1flox/flox;Arf flox/flox;PostnCre+ mice,0.85,Accept,Experimental Usage,Nf1flox/flox;Arf flox/flox;PostnCre+,,,Neurofibromatosis type 1,,,,,,
PMID:28525381,10.18632/oncotarget.17589,The cell of origin dictates the temporal course of neurofibromatosis-1 (Nf1) low-grade glioma formation.,,Nf1+/ − mice [ 30 ] were bred with Nf1 f/wt mice to produce Nf1 flox/mut mice,0.9,Accept,Experimental Usage,Nf1+/−,C57Bl/6,,Neurofibromatosis type 1,Optic Nerve Glioma,,,,,
PMID:28525381,10.18632/oncotarget.17589,The cell of origin dictates the temporal course of neurofibromatosis-1 (Nf1) low-grade glioma formation.,,Nf1+/ − mice [ 30 ] were bred with Nf1 f/wt mice to produce Nf1 flox/mut mice,0.9,Accept,Experimental Usage,Nf1flox/wt,C57Bl/6,,Neurofibromatosis type 1,Optic Nerve Glioma,,,,,
PMID:28525381,10.18632/oncotarget.17589,The cell of origin dictates the temporal course of neurofibromatosis-1 (Nf1) low-grade glioma formation.,,Nf1+/ − mice [ 30 ] were bred with Nf1 f/wt mice to produce Nf1 flox/mut mice,0.9,Accept,Experimental Usage,Nf1flox/mut,C57Bl/6,,Neurofibromatosis type 1,Optic Nerve Glioma,,,,,
PMID:28525381,10.18632/oncotarget.17589,The cell of origin dictates the temporal course of neurofibromatosis-1 (Nf1) low-grade glioma formation.,,intercrossed with Nf1 flox/flox ; Olig2-Cre mice to generate Nf1 flox/mut ; Olig2-Cre (FMOC) mice,0.9,Accept,Experimental Usage,Nf1flox/flox; Olig2-Cre,C57Bl/6,,Neurofibromatosis type 1,Optic Nerve Glioma,,,,,
PMID:28525381,10.18632/oncotarget.17589,The cell of origin dictates the temporal course of neurofibromatosis-1 (Nf1) low-grade glioma formation.,,intercrossed with Nf1 flox/flox ; Olig2-Cre mice to generate Nf1 flox/mut ; Olig2-Cre (FMOC) mice,0.9,Accept,Experimental Usage,Nf1flox/mut; Olig2-Cre,C57Bl/6,,Neurofibromatosis type 1,Optic Nerve Glioma,,,,,
PMID:28525381,10.18632/oncotarget.17589,The cell of origin dictates the temporal course of neurofibromatosis-1 (Nf1) low-grade glioma formation.,,while Nf1 flox/mut ; GFAP-Cre (FMC; [ 11 ]) and Nf1 flox/flox [ 31 ] control mice were established,0.9,Accept,Experimental Usage,Nf1flox/mut; GFAP-Cre,C57Bl/6,,Neurofibromatosis type 1,Optic Nerve Glioma,,,,,
PMID:28525381,10.18632/oncotarget.17589,The cell of origin dictates the temporal course of neurofibromatosis-1 (Nf1) low-grade glioma formation.,,while Nf1 flox/mut ; GFAP-Cre (FMC; [ 11 ]) and Nf1 flox/flox [ 31 ] control mice were established,0.9,Accept,Experimental Usage,Nf1flox/flox,C57Bl/6,,Neurofibromatosis type 1,,,,,,
PMID:28525381,10.18632/oncotarget.17589,The cell of origin dictates the temporal course of neurofibromatosis-1 (Nf1) low-grade glioma formation.,,Nf1 flox/mut mice were also intercrossed with Nf1 flox/flox ; Prom1-Cre ER mice [ 22 ] to generate Nf1 flox/mut ; Prom1-Cre ER (FMPrC) mice,0.9,Accept,Experimental Usage,Nf1flox/flox; Prom1-CreER,C57Bl/6,,Neurofibromatosis type 1,Optic Nerve Glioma,,,,,
PMID:28525381,10.18632/oncotarget.17589,The cell of origin dictates the temporal course of neurofibromatosis-1 (Nf1) low-grade glioma formation.,,Nf1 flox/mut mice were also intercrossed with Nf1 flox/flox ; Prom1-Cre ER mice [ 22 ] to generate Nf1 flox/mut ; Prom1-Cre ER (FMPrC) mice,0.9,Accept,Experimental Usage,Nf1flox/mut; Prom1-CreER,C57Bl/6,,Neurofibromatosis type 1,Optic Nerve Glioma,,,,,
PMID:28525381,10.18632/oncotarget.17589,The cell of origin dictates the temporal course of neurofibromatosis-1 (Nf1) low-grade glioma formation.,,"Olig2-Cre mice (B6-Olig2 tm2 (TVA, cre)Rth /J; Jackson Laboratory; [ 20 ])",0.95,Accept,Experimental Usage,"B6-Olig2tm2(TVA,cre)Rth/J",C57BL/6,,No known disease,,,,,,
PMID:28525381,10.18632/oncotarget.17589,The cell of origin dictates the temporal course of neurofibromatosis-1 (Nf1) low-grade glioma formation.,,"Olig2-Cre mice (B6-Olig2 tm2 (TVA, cre)Rth /J; Jackson Laboratory; [ 20 ]) and GFAP-Cre mice [ 32 ]",0.9,Accept,Experimental Usage,GFAP-Cre,C57Bl/6,,No known disease,,,,,,
PMID:28525381,10.18632/oncotarget.17589,The cell of origin dictates the temporal course of neurofibromatosis-1 (Nf1) low-grade glioma formation.,,Rosa-GREEN mice (B6.Cg- Gt(ROSA)26Sor tm(CAGZsGreen1)Hze+ / J; Jackson Laboratory),0.95,Accept,Experimental Usage,B6.Cg-Gt(ROSA)26Sortm(CAGZsGreen1)Hze+/J,C57BL/6,,No known disease,,,,,,
PMID:31527226,10.1158/1535-7163.MCT-19-0123,"Ketotifen Modulates Mast Cell Chemotaxis to Kit-Ligand, but Does Not Impact Mast Cell Numbers, Degranulation, or Tumor Behavior in Neurofibromas of ",,The Nf1;flox/flox PostnCre+ mice were developed and bred by the Clapp Laboratory utilizing tools reported previously (18). Tumor formation is driven by the early embryonic conditional deletion of Nf1 in Schwann cell progenitors via the Periostin (Postn) promoter and Cre recombinase enzyme,0.95,Accept,Experimental Usage,Nf1flox/flox;PostnCre+,,,Neurofibromatosis type 1,Neurofibromas,,,,,
PMID:35789380,10.1158/2159-8290.CD-21-1671,PRC2-Inactivating Mutations in Cancer Enhance Cytotoxic Response to DNMT1-Targeted Therapy via Enhanced Viral Mimicry.,,"Eed-isogenic mouse MPNST cells were generated as follows: Eed f/f mice (67, 68) were bred with PLP-CreERT:: Nf1 f/f ; Cdkn2a f/f mice",0.85,Accept,Experimental Usage,Eed f/f,,,No known disease,,,,,,
PMID:35789380,10.1158/2159-8290.CD-21-1671,PRC2-Inactivating Mutations in Cancer Enhance Cytotoxic Response to DNMT1-Targeted Therapy via Enhanced Viral Mimicry.,,"Eed f/f mice (67, 68) were bred with PLP-CreERT:: Nf1 f/f ; Cdkn2a f/f mice",0.9,Accept,Experimental Usage,PLP-CreERT:: Nf1 f/f ; Cdkn2a f/f,,,Neurofibromatosis type 1,Malignant Peripheral Nerve Sheath Tumor,,,,,
PMID:35789380,10.1158/2159-8290.CD-21-1671,PRC2-Inactivating Mutations in Cancer Enhance Cytotoxic Response to DNMT1-Targeted Therapy via Enhanced Viral Mimicry.,,"Eed-isogenic cells were infected with sgRNA lentiviruses for additional knockout of Cdkn2b followed by subcutaneous implantation into CB-17 SCID mice (Taconic, RRID:IMSR_TAC:cb17sc)",0.95,Accept,Experimental Usage,CB-17 SCID,CB-17,,No known disease,,,,,,
PMID:32839340,10.1073/pnas.2008391117,Brain-wide structural and functional disruption in mice with oligodendrocyte-specific ,,Inducible Plp-Cre (66) and Nf1 fl/+ (67) mice were maintained on a pure C57BL/6 background,0.9,Accept,Experimental Usage,Plp-Cre,C57BL/6,,No known disease,,,,,,
PMID:32839340,10.1073/pnas.2008391117,Brain-wide structural and functional disruption in mice with oligodendrocyte-specific ,,Inducible Plp-Cre (66) and Nf1 fl/+ (67) mice were maintained on a pure C57BL/6 background,0.95,Accept,Experimental Usage,Nf1 fl/+,C57BL/6,,Neurofibromatosis type 1,,,,,,
PMID:38216572,10.1038/s41467-024-44755-9,Functional interactions between neurofibromatosis tumor suppressors underlie Schwann cell tumor de-differentiation and treatment resistance.,,Subcutaneous allografts were performed by implanting 5 million JW18.2 or JW23.3 MPNST allografts cells into the flanks of 5–6-week-old female NU/NU mice (Harlan Sprague Dawley),0.9,Accept,Experimental Usage,NU/NU,,,No known disease,,,,,,
PMID:36148553,10.1093/brain/awac342,Inhibition of YAP/TAZ-driven TEAD activity prevents growth of NF2-null schwannoma and meningioma.,,Periostin-CRE mice were provided by S.Conway (Indiana University) and crossed with NF2 fl/fl animals (RIKEN Bioresource Research Centre) to make Periostin-CRE;NF2 fl/fl animals,0.9,Accept,Experimental Usage,Periostin-CRE;NF2 fl/fl,,,Neurofibromatosis type 2,,,,,,
PMID:36148553,10.1093/brain/awac342,Inhibition of YAP/TAZ-driven TEAD activity prevents growth of NF2-null schwannoma and meningioma.,,crossed with YAP fl/fl or TAZ fl/fl mice to generate Periostin-CRE;NF2 fl/fl YAP fl/fl (NF2 fl/fl YAP fl/fl -CRE+),0.9,Accept,Experimental Usage,Periostin-CRE;NF2 fl/fl YAP fl/fl,,,Neurofibromatosis type 2,,,,,,
PMID:36148553,10.1093/brain/awac342,Inhibition of YAP/TAZ-driven TEAD activity prevents growth of NF2-null schwannoma and meningioma.,,"Periostin-CRE;NF2 fl/fl TAZ fl/fl (NF2 fl/fl TAZ fl/fl -CRE+) mice, respectively, resulting in additional deletion of YAP or TAZ",0.9,Accept,Experimental Usage,Periostin-CRE;NF2 fl/fl TAZ fl/fl,,,Neurofibromatosis type 2,,,,,,
PMID:36148553,10.1093/brain/awac342,Inhibition of YAP/TAZ-driven TEAD activity prevents growth of NF2-null schwannoma and meningioma.,,Schwann cell-specific NF2-null mice generated with the P0-CRE line and the sciatic nerve injury model have been described,0.85,Accept,Experimental Usage,P0-CRE,,,Neurofibromatosis type 2,,,,,,
PMID:32438526,10.1002/lary.28671,Effects of Neurod1 Expression on Mouse and Human Schwannoma Cells.,,Periostin-cre (Postn-cre) were crossed with floxed Nf2 gene (Postn-cre;Nf2) as previously described.,0.9,Accept,Experimental Usage,Postn-cre,,,No known disease,,,,,,
PMID:32438526,10.1002/lary.28671,Effects of Neurod1 Expression on Mouse and Human Schwannoma Cells.,,Postn-cre were crossed with floxed Nf2 gene (Postn-cre;Nf2f/f) as previously described.,0.95,Accept,Experimental Usage,Postn-cre;Nf2f/f,,,Neurofibromatosis type 2,Schwannoma,,,,,
PMID:32438526,10.1002/lary.28671,Effects of Neurod1 Expression on Mouse and Human Schwannoma Cells.,,Rosa26 (LSL-Neurod1 R26ND1) line that induces Neurod1 expression via cre-mediated excision of a stop codon,0.9,Accept,Experimental Usage,Rosa26 LSL-Neurod1 (R26ND1),,,No known disease,,,,,,
PMID:32438526,10.1002/lary.28671,Effects of Neurod1 Expression on Mouse and Human Schwannoma Cells.,,we used the following mouse lines: tg(Atoh1-cre)8; R26smo and tg(Neurod1-cre)29 to generate fast and slow growing medulloblastoma,0.85,Accept,Experimental Usage,tg(Atoh1-cre)8,,,No known disease,,,,,,
PMID:32438526,10.1002/lary.28671,Effects of Neurod1 Expression on Mouse and Human Schwannoma Cells.,,we used the following mouse lines: tg(Atoh1-cre)8; R26smo and tg(Neurod1-cre)29 to generate fast and slow growing medulloblastoma,0.85,Accept,Experimental Usage,tg(Neurod1-cre)29,,,No known disease,,,,,,
PMID:32438526,10.1002/lary.28671,Effects of Neurod1 Expression on Mouse and Human Schwannoma Cells.,,we used the widely available R26LacZ reporter mice to verify that the Postn-cre effectively and exclusively recombines,0.8,Accept,Experimental Usage,R26LacZ,,,No known disease,,,,,,
PMID:32396062,10.7554/eLife.55137,Tgfb3 collaborates with PP2A and notch signaling pathways to inhibit retina regeneration.,,"Strain, strain background (Danio rerio) 1016 tuba1a:GFP Fausett and Goldman, 2006",0.9,Accept,Experimental Usage,1016 tuba1a:GFP,Danio rerio,,No known disease,,,,,,
PMID:32396062,10.7554/eLife.55137,Tgfb3 collaborates with PP2A and notch signaling pathways to inhibit retina regeneration.,,"Strain, strain background (Danio rerio) gfap:GFP Kassen et al., 2007",0.9,Accept,Experimental Usage,gfap:GFP,Danio rerio,,No known disease,,,,,,
PMID:32396062,10.7554/eLife.55137,Tgfb3 collaborates with PP2A and notch signaling pathways to inhibit retina regeneration.,,"Strain, strain background (Danio rerio) tp1:mCherry Parsons et al., 2009",0.9,Accept,Experimental Usage,tp1:mCherry,Danio rerio,,No known disease,,,,,,
PMID:32396062,10.7554/eLife.55137,Tgfb3 collaborates with PP2A and notch signaling pathways to inhibit retina regeneration.,,"Strain, strain background (Danio rerio) zop:nsfb-EGFP Montgomery et al., 2010",0.9,Accept,Experimental Usage,zop:nsfb-EGFP,Danio rerio,,No known disease,,,,,,
PMID:32396062,10.7554/eLife.55137,Tgfb3 collaborates with PP2A and notch signaling pathways to inhibit retina regeneration.,,"Strain, strain background (Danio rerio) hsp70:ca-Alk5 Zhou et al., 2011",0.9,Accept,Experimental Usage,hsp70:ca-Alk5,Danio rerio,,No known disease,,,,,,
PMID:32396062,10.7554/eLife.55137,Tgfb3 collaborates with PP2A and notch signaling pathways to inhibit retina regeneration.,,"Strain, strain background (Danio rerio) hsp70:tgfb1b This paper; Figure 5 tgfb1b expressed under the hsp70 promoter",0.9,Accept,Development,hsp70:tgfb1b,Danio rerio,,No known disease,,,,,,
PMID:32396062,10.7554/eLife.55137,Tgfb3 collaborates with PP2A and notch signaling pathways to inhibit retina regeneration.,,"Strain, strain background (Danio rerio) hsp70:tgfb3 This paper; Figure 4 tgfb3 expressed under the hsp70 promoter",0.9,Accept,Development,hsp70:tgfb3,Danio rerio,,No known disease,,,,,,
PMID:33356508,10.1177/0963689720964383,C6 Cell Injection into the Optic Nerve of Long-Evans Rats: A Short-Term Model of Optic Pathway Gliomas.,,Twenty-four domestic rats of the Long-Evans strain (age 4 weeks with approximate weight of 150 g) were used as control and test recipients,0.95,Accept,Experimental Usage,Long-Evans,,,No known disease,Optic Pathway Glioma,,,,,
PMID:40723243,10.3390/cancers17142359,The Combination of HSP90 Inhibitors and Selumetinib Reinforces the Inhibitory Effects on Plexiform Neurofibromas.,,pNF tumors were generated in nude mice by transplanting tumor cells harvested from dorsal root ganglia with DhhCre;Nf1f/f;Luciferase configuration,0.85,Accept,Experimental Usage,DhhCre;Nf1f/f;Luciferase,,,Neurofibromatosis type 1,Plexiform Neurofibroma,,,,,
PMID:34647023,10.1093/noajnl/vdab129,A genetic mouse model with postnatal ,,"NPcis (Stock #008191), Nf1 (#017640), fl Trp53 (#008462), fl Plp-CreER (#005975), and T Nestin-Cre (#003771) were obtained from The Jackson Laboratory.",0.9,Accept,Experimental Usage,NPcis (Stock #008191),B6;129,,Neurofibromatosis type 1,Malignant Peripheral Nerve Sheath Tumor,,,,,
PMID:34647023,10.1093/noajnl/vdab129,A genetic mouse model with postnatal ,,"NPcis (Stock #008191), Nf1 (#017640), fl Trp53 (#008462), fl Plp-CreER (#005975), and T Nestin-Cre (#003771) were obtained from The Jackson Laboratory.",0.9,Accept,Experimental Usage,Nf1 (#017640),B6;129,,Neurofibromatosis type 1,,,,,,
PMID:34647023,10.1093/noajnl/vdab129,A genetic mouse model with postnatal ,,"NPcis (Stock #008191), Nf1 (#017640), fl Trp53 (#008462), fl Plp-CreER (#005975), and T Nestin-Cre (#003771) were obtained from The Jackson Laboratory.",0.9,Accept,Experimental Usage,fl Trp53 (#008462),B6;129,,No known disease,,,,,,
PMID:34647023,10.1093/noajnl/vdab129,A genetic mouse model with postnatal ,,"NPcis (Stock #008191), Nf1 (#017640), fl Trp53 (#008462), fl Plp-CreER (#005975), and T Nestin-Cre (#003771) were obtained from The Jackson Laboratory.",0.9,Accept,Experimental Usage,fl Plp-CreER (#005975),C57BL/6J,,No known disease,,,,,,
PMID:34647023,10.1093/noajnl/vdab129,A genetic mouse model with postnatal ,,"NPcis (Stock #008191), Nf1 (#017640), fl Trp53 (#008462), fl Plp-CreER (#005975), and T Nestin-Cre (#003771) were obtained from The Jackson Laboratory.",0.9,Accept,Experimental Usage,T Nestin-Cre (#003771),C57BL/6J,,No known disease,,,,,,
PMID:15240917,10.1155/S1110724304308107,Survival of Human Neurofibroma in Immunodeficient Mice and Initial Results of Therapy With Pirfenidone.,,Mice with severe combined immunodeficiency (SCID) were used as recipients of human neurofibroma xenotransplants,0.9,Accept,Experimental Usage,SCID,,,No known disease,Immunodeficiency for xenograft studies,,,,,
PMID:21963652,10.1016/j.expneurol.2011.09.005,PET imaging for attention deficit preclinical drug testing in neurofibromatosis-1 mice.,,Nf1 +/− GFAP CKO (CKO) and control littermate Nf1 flox/flox (WT) mice were maintained on an inbred C57BL/6 background,0.95,Accept,Experimental Usage,Nf1+/− GFAP CKO,C57BL/6,,Neurofibromatosis type 1,attention deficit,,,,,
PMID:21963652,10.1016/j.expneurol.2011.09.005,PET imaging for attention deficit preclinical drug testing in neurofibromatosis-1 mice.,,control littermate Nf1 flox/flox (WT) mice were maintained on an inbred C57BL/6 background,0.9,Accept,Experimental Usage,Nf1 flox/flox,C57BL/6,,No known disease,,,,,,
PMID:39415595,10.1242/dmm.050862,Generation of a zebrafish neurofibromatosis model via inducible knockout of nf2a/b.,,"Transgenic lines used in this study were the ABWT (Zebrafish International Resource Center), Tg(HOTCre:Cas9) (a kind gift from Dr Wenbiao Chen, Vanderbilt University School of Medicine)",0.9,Accept,Experimental Usage,Tg(HOTCre:Cas9),,,No known disease,,,,,,
PMID:39415595,10.1242/dmm.050862,Generation of a zebrafish neurofibromatosis model via inducible knockout of nf2a/b.,,"Transgenic lines used in this study were the ABWT (Zebrafish International Resource Center), Tg(HOTCre:Cas9) (a kind gift from Dr Wenbiao Chen, Vanderbilt University School of Medicine, Nashville, TN, USA), Tg(−7.2kb-sox10:mRFP)",0.9,Accept,Experimental Usage,Tg(-7.2kb-sox10:mRFP),,,No known disease,,,,,,
PMID:39415595,10.1242/dmm.050862,Generation of a zebrafish neurofibromatosis model via inducible knockout of nf2a/b.,,"Transgenic lines used in this study were the ABWT (Zebrafish International Resource Center), Tg(HOTCre:Cas9) (a kind gift from Dr Wenbiao Chen, Vanderbilt University School of Medicine, Nashville, TN, USA), Tg(−7.2kb-sox10:mRFP) and Tg(U6x:nf2a/b-4sgRNA) (generated at the Bronner laboratory, Caltech) lines.",0.95,Accept,Development,Tg(U6x:nf2a/b-4sgRNA),,,Neurofibromatosis type 2,,,,,,
PMID:39415595,10.1242/dmm.050862,Generation of a zebrafish neurofibromatosis model via inducible knockout of nf2a/b.,,Transgenic lines used in this study were the ABWT (Zebrafish International Resource Center),0.85,Accept,Experimental Usage,ABWT,,,No known disease,,,,,,
PMID:37246765,10.1093/neuonc/noad097,Ex vivo to in vivo model of malignant peripheral nerve sheath tumors for precision oncology.,,Tumor tissue was implanted dorsally into 5- to 6-week-old NOD- Rag1 null IL2rg (NRG) mice.,0.9,Accept,Experimental Usage,NOD-Rag1 null IL2rg (NRG),,,No known disease,,,,,,
PMID:33978635,10.1093/noajnl/vdab020,Selumetinib normalizes Ras/MAPK signaling in clinically relevant neurofibromatosis type 1 minipig tissues in vivo.,,"To generate a minipig model of NF1, we mimicked a recurrent nonsense mutation p.Arg1947X (R1947X) identified in 62 of 8100 (± 8) unrelated and symptomatic NF1 patients",0.95,Accept,Development,NF1 R1947X minipig,Ossabaw minipig,,Neurofibromatosis type 1,,,,,,
PMID:24375753,10.1002/ana.24093,Sex Is a major determinant of neuronal dysfunction in neurofibromatosis type 1.,,"Nf1 +/- GFAP CKO ( Nf1 flox/mut ;GFAP-Cre,  Nf1 -CKO) and littermate control ( Nf1 flox/flox ; CTL) mice were maintained on an inbred C57BL/6 background",0.95,Accept,Experimental Usage,Nf1flox/mut;GFAP-Cre,C57BL/6,,Neurofibromatosis type 1,Optic Nerve Glioma,,,,,
PMID:24375753,10.1002/ana.24093,Sex Is a major determinant of neuronal dysfunction in neurofibromatosis type 1.,,"Nf1 +/- GFAP CKO ( Nf1 flox/mut ;GFAP-Cre,  Nf1 -CKO) and littermate control ( Nf1 flox/flox ; CTL) mice were maintained on an inbred C57BL/6 background",0.9,Accept,Experimental Usage,Nf1flox/flox,C57BL/6,,No known disease,,,,,,
PMID:25043591,10.1002/jbmr.2316,Combined MEK inhibition and BMP2 treatment promotes osteoblast differentiation and bone healing in Nf1Osx -/- mice.,,WT and Nf1 mice (herein called TetOff-Osx −/− Nf1 mice) were generated by crossing Osx −/− Nf1 flox/flox mice,0.9,Accept,Experimental Usage,TetOff-Osx-/-Nf1,,,Neurofibromatosis type 1,pseudoarthrosis,,,,,
PMID:25043591,10.1002/jbmr.2316,Combined MEK inhibition and BMP2 treatment promotes osteoblast differentiation and bone healing in Nf1Osx -/- mice.,,"generated by crossing Osx −/− Nf1 flox/flox mice ( 11 ) and Osx -tTA, tetO -cre; Nf1 flox/flox mice",0.85,Accept,Experimental Usage,Osx-/-Nf1flox/flox,,,Neurofibromatosis type 1,,,,,,
PMID:25043591,10.1002/jbmr.2316,Combined MEK inhibition and BMP2 treatment promotes osteoblast differentiation and bone healing in Nf1Osx -/- mice.,,"crossing Osx −/− Nf1 flox/flox mice ( 11 ) and Osx -tTA, tetO -cre; Nf1 flox/flox mice ( 12 )",0.85,Accept,Experimental Usage,"Osx-tTA,tetO-cre;Nf1flox/flox",,,Neurofibromatosis type 1,,,,,,
PMID:24371224,10.1158/0008-5472.CAN-13-2062,Tumor suppressor alterations cooperate to drive aggressive mesotheliomas with enriched cancer stem cells via a p53-miR-34a-c-Met axis.,,"p16/p19+/− (01XB2, FVB/N.129-Cdkn2atm1Rdp) mice, obtained from the Mouse Models of Human Cancers Consortium, were crossed to Nf2 mice",0.9,Accept,Experimental Usage,FVB/N.129-Cdkn2atm1Rdp,FVB,,No known disease,,,,,,
PMID:24371224,10.1158/0008-5472.CAN-13-2062,Tumor suppressor alterations cooperate to drive aggressive mesotheliomas with enriched cancer stem cells via a p53-miR-34a-c-Met axis.,,p16/p19+/− mice were crossed to Nf2 mice to obtain all of the genotypes used herein. All mice were in a comparable FVB genetic background,0.85,Accept,Experimental Usage,Nf2 mice,FVB,,Neurofibromatosis type 2,,,,,,
PMID:24371224,10.1158/0008-5472.CAN-13-2062,Tumor suppressor alterations cooperate to drive aggressive mesotheliomas with enriched cancer stem cells via a p53-miR-34a-c-Met axis.,,0.5 × 106 or 1.0 × 106 murine MM cells were injected into the tail vein of recipient SCID mice,0.8,Accept,Experimental Usage,SCID mice,,,No known disease,,,,,,
PMID:19144871,10.3181/0809-RM-275,Identification of erythrocyte p55/MPP1 as a binding partner of NF2 tumor suppressor protein/Merlin.,,The anti-p55 mouse monoclonal antibody was generated by immunizing BALB/c mice with the recombinant SH3-GUK segment,0.8,Accept,Experimental Usage,BALB/c,BALB/c,,No known disease,,,,,,
PMID:23071067,10.1158/0008-5472.CAN-12-1728,Genetically mediated Nf1 loss in mice promotes diverse radiation-induced tumors modeling second malignant neoplasms.,,"Nf1+/- and wildtype mice were generated as previously described. In brief, Nf1+/- mice maintained in the 129/Sv background were crossed with wild-type C57Bl/6 mice.",0.95,Accept,Experimental Usage,Nf1+/-,129/Sv x C57BL/6,,Neurofibromatosis type 1,,,,,,
PMID:16835260,10.1093/hmg/ddl165,Nf1+/- mast cells induce neurofibroma like phenotypes through secreted TGF-beta signaling.,,"Nf1 +/− mice were obtained from Dr Tyler Jacks at the Massachusetts Institute of Technology (Cambridge, MA, USA) in a C57BL/6J.129 background and backcrossed for 13 generations into a C57BL/6J strain",0.9,Accept,Experimental Usage,Nf1+/-,C57BL/6J,,Neurofibromatosis type 1,,,,,,
PMID:36241865,10.1038/s12276-022-00850-9,Transplanting neurofibromatosis-1 gene knockout neural stem cells improve functional recovery in rats with spinal cord injury by enhancing the mTORC2 pathway.,,"NSCs were obtained from the fetal brains of embryonic Day 14 pregnant Sprague‒Dawley rats (Experimental Animal Center of Southern Medical University, Guangzhou, China)",0.85,Accept,Experimental Usage,Sprague‒Dawley,Sprague‒Dawley,,No known disease,,,,,,
PMID:24817309,10.1371/journal.pone.0097320,Nf2/Merlin controls spinal cord neural progenitor function in a Rac1/ErbB2-dependent manner.,,Nf2flox/flox mice carrying a LoxP insertion in the Nf2 gene [13] were maintained at the Washington University School of Medicine,0.9,Accept,Experimental Usage,Nf2flox/flox,C57BL/6 and FVB/N,,Neurofibromatosis type 2,,,,,,
PMID:25535838,10.7554/eLife.05151,Transient inhibition of the ERK pathway prevents cerebellar developmental defects and improves long-term motor functions in murine models of neurofibromatosis type 1.,,"Three independent Cre transgenic strains under the control of hGFAP, Math1 and L7 promoters were utilized to target an Nf1 mutation into different cell lineages",0.9,Accept,Experimental Usage,hGFAP-cre,"C57Bl6, 129Svj and FVB",,Neurofibromatosis type 1,,,,,,
PMID:25535838,10.7554/eLife.05151,Transient inhibition of the ERK pathway prevents cerebellar developmental defects and improves long-term motor functions in murine models of neurofibromatosis type 1.,,"Three independent Cre transgenic strains under the control of hGFAP, Math1 and L7 promoters were utilized to target an Nf1 mutation into different cell lineages",0.9,Accept,Experimental Usage,Math1-cre,"C57Bl6, 129Svj and FVB",,Neurofibromatosis type 1,,,,,,
PMID:25535838,10.7554/eLife.05151,Transient inhibition of the ERK pathway prevents cerebellar developmental defects and improves long-term motor functions in murine models of neurofibromatosis type 1.,,"Three independent Cre transgenic strains under the control of hGFAP, Math1 and L7 promoters were utilized to target an Nf1 mutation into different cell lineages",0.9,Accept,Experimental Usage,L7-cre,"C57Bl6, 129Svj and FVB",,Neurofibromatosis type 1,,,,,,
PMID:25535838,10.7554/eLife.05151,Transient inhibition of the ERK pathway prevents cerebellar developmental defects and improves long-term motor functions in murine models of neurofibromatosis type 1.,,The control mice for Nf1 hGFAP CKO mice are a pool of phenotypically indistinguishable mice: hGFAP-cre-; Nf1 flox/flox,0.9,Accept,Experimental Usage,Nf1 flox/flox,"C57Bl6, 129Svj and FVB",,Neurofibromatosis type 1,,,,,,
PMID:25535838,10.7554/eLife.05151,Transient inhibition of the ERK pathway prevents cerebellar developmental defects and improves long-term motor functions in murine models of neurofibromatosis type 1.,,Tamoxifen inducible strain Nf1 NcreER CKO is described in later sections along with the tamoxifen administration protocol,0.9,Accept,Experimental Usage,Nestin-creER,,,Neurofibromatosis type 1,,,,,,
PMID:25535838,10.7554/eLife.05151,Transient inhibition of the ERK pathway prevents cerebellar developmental defects and improves long-term motor functions in murine models of neurofibromatosis type 1.,,"The R26 LacZR allele was introduced to the control, Nf1 hGFAP CKO, Nf1 Math1 CKO, Nf1 L7 CKO and Nf1 NcreER CKO mice as a reporter",0.9,Accept,Experimental Usage,R26 LacZR,,,No known disease,,,,,,
PMID:26190969,10.3389/fncel.2015.00234,"In vivo synaptic transmission and morphology in mouse models of Tuberous sclerosis, Fragile X syndrome, Neurofibromatosis type 1, and Costello syndrome.",,"Generation of the Fmr1 KO (Mientjes et al., 2006)...Calyces from both Tsc1(+/-) and from Fmr1 knock-out (KO) mice showed increased volume",0.85,Accept,Experimental Usage,Fmr1 KO,C57BL/6J,,No known disease,,,,,,
PMID:26190969,10.3389/fncel.2015.00234,"In vivo synaptic transmission and morphology in mouse models of Tuberous sclerosis, Fragile X syndrome, Neurofibromatosis type 1, and Costello syndrome.",,"Generation of the...Nf1 (+/- Jacks et al., 1994)...In MNTB principal neurons of Nf1 (+/-) mice the average delay between EPSPs and APs was slightly smaller",0.95,Accept,Experimental Usage,Nf1 (+/-),C57BL/6J,,Neurofibromatosis type 1,,,,,,
PMID:26190969,10.3389/fncel.2015.00234,"In vivo synaptic transmission and morphology in mouse models of Tuberous sclerosis, Fragile X syndrome, Neurofibromatosis type 1, and Costello syndrome.",,"Generation of the...H-ras mice (G12V Schuhmacher et al., 2008) has been described previously",0.85,Accept,Experimental Usage,H-ras G12V,C57BL/6J,,No known disease,,,,,,
PMID:26190969,10.3389/fncel.2015.00234,"In vivo synaptic transmission and morphology in mouse models of Tuberous sclerosis, Fragile X syndrome, Neurofibromatosis type 1, and Costello syndrome.",,"Tsc1 animals were obtained by crossing the +/- Tsc1 line (f/+ Meikle et al., 2005)...Calyces from both Tsc1(+/-) and from Fmr1 knock-out (KO) mice showed increased volume",0.85,Accept,Experimental Usage,Tsc1 (+/-),C57BL/6J,,No known disease,,,,,,
PMID:26190969,10.3389/fncel.2015.00234,"In vivo synaptic transmission and morphology in mouse models of Tuberous sclerosis, Fragile X syndrome, Neurofibromatosis type 1, and Costello syndrome.",,"Tsc1 animals were obtained by crossing the +/- Tsc1 line (f/+ Meikle et al., 2005) once with CAGG-Cre mice to obtain germ-line deletion",0.8,Accept,Experimental Usage,CAGG-Cre,C57BL/6J,,No known disease,,,,,,
PMID:33591953,10.1172/jci.insight.146351,Chromosome 8 gain is associated with high-grade transformation in MPNST.,,Tumor tissue was implanted s.c. into the flank of 5- to 6-week-old NSG mice (The Jackson Laboratory).,0.85,Accept,Experimental Usage,NSG,,,No known disease,,,,,,
PMID:37410426,10.1158/1078-0432.CCR-23-0749,"CDK4/6-MEK Inhibition in MPNSTs Causes Plasma Cell Infiltration, Sensitization to PD-L1 Blockade, and Tumor Regression.",,viral injection into the left sciatic nerve of wild-type C57BL/6N mice,0.85,Accept,Experimental Usage,C57BL/6N,C57BL/6,C57BL/6N,No known disease,,,,,,
PMID:37410426,10.1158/1078-0432.CCR-23-0749,"CDK4/6-MEK Inhibition in MPNSTs Causes Plasma Cell Infiltration, Sensitization to PD-L1 Blockade, and Tumor Regression.",,injected into the left sciatic nerve of immunodeficient (NOD scid gamma) mice,0.85,Accept,Experimental Usage,NOD scid gamma,,,No known disease,,,,,,
PMID:37410426,10.1158/1078-0432.CCR-23-0749,"CDK4/6-MEK Inhibition in MPNSTs Causes Plasma Cell Infiltration, Sensitization to PD-L1 Blockade, and Tumor Regression.",,implanted subcutaneously with Matrigel in immunodeficient NRG (NOD RAG1/2−/− IL2Rγ−/−) mice,0.85,Accept,Experimental Usage,NOD RAG1/2−/− IL2Rγ−/−,,,No known disease,,,,,,
PMID:33658640,10.1038/s41416-021-01270-8,Exploring transcriptional regulators Ref-1 and STAT3 as therapeutic targets in malignant peripheral nerve sheath tumours.,,"Tissue processing for wild-type (wt), Nf1 flox/flox- ;Postn-Cre and Nf1-Arf flox/flox ;Postn-Cre mouse tissues",0.9,Accept,Experimental Usage,Nf1 flox/flox-;Postn-Cre,,,Neurofibromatosis type 1,,,,,,
PMID:33658640,10.1038/s41416-021-01270-8,Exploring transcriptional regulators Ref-1 and STAT3 as therapeutic targets in malignant peripheral nerve sheath tumours.,,"Tissue processing for wild-type (wt), Nf1 flox/flox- ;Postn-Cre and Nf1-Arf flox/flox ;Postn-Cre mouse tissues",0.9,Accept,Experimental Usage,Nf1-Arf flox/flox ;Postn-Cre,,,Neurofibromatosis type 1,,,,,,
PMID:33658640,10.1038/s41416-021-01270-8,Exploring transcriptional regulators Ref-1 and STAT3 as therapeutic targets in malignant peripheral nerve sheath tumours.,,NOD.Cg-Prkdc scid Il2rg tm1Wjl /SzJ (NSG) male mice (6–8 weeks of age) were obtained from the on-site breeding colony,0.95,Accept,Experimental Usage,NOD.Cg-Prkdc scid Il2rg tm1Wjl /SzJ,NOD,,No known disease,,,,,,
PMID:38945076,10.1016/j.redox.2024.103249,Selective nitration of Hsp90 acts as a metabolic switch promoting tumor cell proliferation.,,"Schwann cells purified from sciatic nerve of Nf2 flox2/flox2 mice, as described previously",0.9,Accept,Experimental Usage,Nf2 flox2/flox2,,,Neurofibromatosis type 2,,,,,,
